{"chunk_type":"transcript_chunk","text":"> â˜… Clinical Pearl: Torsionì€ í—ˆí˜ˆ(Ischemia) ë°˜ì‘ì´ë¯€ë¡œ ë‚´ì¥ ë°˜ì‘ì¸ êµ¬í† ê°€ ë™ë°˜ë˜ëŠ” ê²ƒì´ Ruptureì™€ì˜ ê°ë³„ì ì…ë‹ˆë‹¤.\n>\n---\n## 5. Ovarian Cancer: The Silent Killer ğŸ•µï¸â€â™€ï¸\n- **ìœ í˜•:** ìƒí”¼ì„±(Epithelial) ì•”ì´ ê°€ì¥ í”í•¨.\n- **ì¦ìƒ:** ë§¤ìš° ëª¨í˜¸í•¨ (ë³µë¶€ íŒ½ë§Œê°, ì†Œí™”ë¶ˆëŸ‰, ì¡°ê¸° í¬ë§Œê°).\n    - ì´ë¡œ ì¸í•´ ëŒ€ë¶€ë¶„ **3ê¸°, 4ê¸° (Late stage)**ì— ë°œê²¬ë¨.\n- **â˜… Pathophysiology (Incessant Ovulation Hypothesis):**\n    - ë°°ë€(Ovulation)ì€ ë‚œì†Œ í‘œë©´ì— ìƒì²˜ë¥¼ ì…íˆê³  íšŒë³µí•˜ëŠ” ê³¼ì •(Trauma & Repair)ì…ë‹ˆë‹¤. ì´ ì„¸í¬ ë¶„ì—´ ê³¼ì •ì´ ë°˜ë³µë ìˆ˜ë¡ ëŒì—°ë³€ì´ ìœ„í—˜ì´ ì¦ê°€í•©ë‹ˆë‹¤.\n### Risk Factors vs. Protective Factors\n| Risk Factors (ë°°ë€ íšŸìˆ˜ â–²) | Protective Factors (ë°°ë€ íšŸìˆ˜ â–¼) |\n| --- | --- |\n| ë¯¸ì‚°ë¶€ (Nulliparity) | **ê²½êµ¬ í”¼ì„ì•½ (OCPs)** - ë‚œì†Œì—ê²Œ íœ´ì‹ì„ ì¤Œ |\n| ì´ë¥¸ ì´ˆê²½ (Early menarche) | ì„ì‹ , ëª¨ìœ  ìˆ˜ìœ  |\n| ëŠ¦ì€ íê²½ (Late menopause) | ë‚œê´€ ê²°ì°°ìˆ  (Tubal ligation) |\n| ìœ ì „: BRCA 1/2, Lynch Syndrome |  |\n### Screening\n- no screening for normal people\n- high risk (BRCA, lynch): TVUS, CA-125 every 6mo from age of 30\n    - ê²°êµ­ ì• ë‚³ìœ¼ë©´ rrBSO\n- **ì§„ë‹¨ ì‹œ ê²€ì‚¬:** CA-125ê°€ ìƒìŠ¹ë˜ì–´ ìˆìœ¼ë©´ CT/MRIë¡œ ì „ì´ ì—¬ë¶€ í™•ì¸.\n- **ì¹˜ë£Œ:** **Surgical Staging (Debulking)** + í•­ì•”í™”í•™ìš”ë²• (Platinum/Taxane ê¸°ë°˜).\n---\n## 6. Special Tumors (Vignette Tumors) ğŸ§ª\níŠ¹ì§•ì ì¸ í˜¸ë¥´ëª¬ ë¶„ë¹„ë‚˜ ì¦ìƒìœ¼ë¡œ \"ì‹œí—˜ì— ì˜ ë‚˜ì˜¤ëŠ”\" ì¢…ì–‘ë“¤ì…ë‹ˆë‹¤.\n### 1) Sex Cord-Stromal Tumors (ì„±ëˆê°„ì§ˆ ì¢…ì–‘)\n- **Sertoli-Leydig Cell Tumor:**\n    - **í…ŒìŠ¤í† ìŠ¤í…Œë¡ (Testosterone) ê³¼ë‹¤.**\n    - ì¦ìƒ: **Virilization (ë‚¨ì„±í™”)** - íƒˆëª¨, ëª©ì†Œë¦¬ êµµì–´ì§, ìŒí•µë¹„ëŒ€(Clitoromegaly).\n- **Granulosa Cell Tumor:**\n    - **ì—ìŠ¤íŠ¸ë¡œê²(Estrogen) ê³¼ë‹¤.**\n    - ì†Œì•„: ì„±ì¡°ìˆ™ì¦ (Precocious puberty).\n    - ì„±ì¸/íê²½ í›„: **Post-menopausal bleeding (íê²½ í›„ ì¶œí˜ˆ)**.\n    - **â˜… Critical Step:** ìê¶ë‚´ë§‰ì´ ì—ìŠ¤íŠ¸ë¡œê² ê³µê²©ì„ ë°›ì•˜ìœ¼ë¯€ë¡œ ë°˜ë“œì‹œ **Endometrial Biopsy (ìê¶ë‚´ë§‰ ìƒê²€)**ì„ í•´ì„œ ìê¶ë‚´ë§‰ì•”ì„ ë°°ì œí•´ì•¼ í•¨.\n    - ì¡°ì§í•™ì  íŠ¹ì§•: **Call-Exner Bodies**.\n### 2) Germ Cell Tumors (ìƒì‹ì„¸í¬ ì¢…ì–‘)\n- **Dysgerminoma:** **LDH** ìƒìŠ¹. ì Šì€ í™˜ì.\n- **Yolk Sac Tumor:** **AFP** ìƒìŠ¹.\n- **Choriocarcinoma:** **Beta-hCG** ìƒìŠ¹.\n---\n## 7. Pregnancy Related Masses ğŸ¤°\nì„ì‹  ì¤‘ ë°œê²¬ë˜ëŠ” ë‚œì†Œ ì¢…ê´´ë“¤ì…ë‹ˆë‹¤.\n- **Luteoma (í™©ì²´ì¢…):** ê³ í˜• ì¢…ê´´(Solid mass). ì‚°ëª¨ì—ê²Œ ë‚¨ì„±í™”(Virilization)ë¥¼ ì¼ìœ¼í‚¬ ìˆ˜ ìˆìŒ.\n    - **Mgmt:** **Don't touch!** ì¶œì‚° í›„ ìì—° í‡´ì¶•(Regress)ë˜ë¯€ë¡œ ê±´ë“œë¦¬ì§€ ì•ŠìŒ.\n- **Theca Lutein Cysts (ë‚œí¬ë§‰í™©ì²´ë‚­ì¢…):**\n    - ì›ì¸: **Molar Pregnancy (í¬ìƒê¸°íƒœ)**ì™€ ê°™ì´ ì—„ì²­ë‚˜ê²Œ ë†’ì€ b-hCG ë ˆë²¨ì— ì˜í•œ ê³¼ìê·¹.\n    - íŠ¹ì§•: ì–‘ì¸¡ì„±(Bilateral)ì˜ ê±°ëŒ€í•œ ë‚­ì¢…ë“¤.\n    - **Mgmt:** ë‚­ì¢…ì„ ìˆ˜ìˆ í•˜ëŠ” ê²ƒì´ ì•„ë‹ˆë¼, ì›ì¸ì¸ **Mole(í¬ìƒê¸°íƒœ)ì„ ì œê±°**í•˜ë©´ ë‚­ì¢…ì€ ì‚¬ë¼ì§.","subject":"LM_gyne 2 2f446f2986ee8041a277d7ea0baa58c8","page_title":"LM_gyne 2 2f446f2986ee8041a277d7ea0baa58c8","episode":"LM_gyne 2 2f446f2986ee8041a277d7ea0baa58c8","section_path":["LM_gyne 2 2f446f2986ee8041a277d7ea0baa58c8"],"source_doc_id":"LM_gyne 2 2f446f2986ee8041a277d7ea0baa58c8","source_page":null,"source_anchor":"LM_gyne 2 2f446f2986ee8041a277d7ea0baa58c8-91"}
{"chunk_type":"transcript_chunk","text":"---\n## âš¡ Rapid Fire Recap (High Yield Summary)\nì˜¤ë””ì˜¤ì˜ ë§ˆì§€ë§‰ì— ì–¸ê¸‰ëœ \"If-Then\" ì‹œë‚˜ë¦¬ì˜¤ ì •ë¦¬ì…ë‹ˆë‹¤.\n1. **If** ê°‘ì‘ìŠ¤ëŸ¬ìš´ í†µì¦, ì˜¤ì‹¬/êµ¬í† , ë„í”ŒëŸ¬ í˜ˆë¥˜ ê°ì†Œ **Then** â†’ **Ovarian Torsion (Emergency Laparoscopy)**.\n2. **If** ì„±ê´€ê³„/í™œë™ í›„ ê°‘ì‘ìŠ¤ëŸ¬ìš´ í†µì¦, ì´ˆìŒíŒŒìƒ Free fluid **Then** â†’ **Ruptured Cyst** (Stableí•˜ë©´ ì§„í†µì œ, Unstableí•˜ë©´ ìˆ˜ìˆ ).\n3. **If** íê²½ í›„ ì—¬ì„± + Adnexal Mass + CA-125 ìƒìŠ¹ **Then** â†’ **Malignancy ì˜ì‹¬ (CT/MRI í›„ ìˆ˜ìˆ )**.\n4. **If** ê¸‰ê²©í•œ ë‚¨ì„±í™”(Virilization), ìŒí•µë¹„ëŒ€ **Then** â†’ **Sertoli-Leydig Cell Tumor** (Testosterone).\n5. **If** ì–´ë¦° ì†Œë…€ì˜ ì„±ì¡°ìˆ™ì¦ **OR** ë…¸ë…„ ì—¬ì„±ì˜ íê²½ í›„ ì¶œí˜ˆ + Mass **Then** â†’ **Granulosa Cell Tumor** (Call-Exner bodies, ìê¶ë‚´ë§‰ ìƒê²€ í•„ìˆ˜).\n6. **If** ì˜ì‹¬ìŠ¤ëŸ¬ìš´ ë‚œì†Œ ì•” ë©ì–´ë¦¬ê°€ ë³´ì„ **Then** â†’ **NEVER Biopsy** (ìˆ˜ìˆ ì  ì œê±°ê°€ ì›ì¹™).\n# ğŸ§ USMLE Step 2 CK: Vulva & Vagina Pathology Deep Dive\n**0:00~0:30 êµ¬ê°„ ë°›ì•„ì“°ê¸° (Dictation Verification)**\n> \"Okay, let's unpack this. You are staring down the barrel of USMLE Step 2. You've got a mountain of material to cover, but today, we are going to laser focus on a very specific high yield territory. That's right, we are tackling the vulva and vagina sections of gynecology. And before you tune out thinking this is just anatomy, hold on. This deep dive isn't just a laundry list of diseases, the mission here is clinical differentiation.\"\n>\n---\n## 1. Introduction: The Art of Differentiation ğŸ¯\nì´ ê°•ì˜ì˜ í•µì‹¬ ë¯¸ì…˜ì€ ë‹¨ìˆœí•œ ì§ˆë³‘ ë‚˜ì—´ì´ ì•„ë‹ˆë¼ **Clinical Differentiation (ì„ìƒì  ê°ë³„)**ì…ë‹ˆë‹¤. ì‹œí—˜ì—ì„œëŠ” ë³‘ë³€ì˜ ìœ„ì¹˜(Clock position)ë‚˜ ë°œì§„(Rash)ì´ ì§ˆ ë‚´ë¶€ì— ìˆëŠ”ì§€ ì™¸ë¶€ì— ìˆëŠ”ì§€ì™€ ê°™ì€ **\"í•œ ë— ì°¨ì´(Single detail)\"**ê°€ ì •ë‹µì„ ê°€ë¦…ë‹ˆë‹¤.\n**ğŸ—ºï¸ Lecture Roadmap:**\n1. **Pediatric Presentations:** ì–´ë¦°ì•„ì´ë“¤ì—ê²Œ ìƒê¸°ëŠ” ë¬¸ì œë“¤\n2. **Itch & Pain (Dermatosis):** Lichen ê´€ë ¨ ì§ˆí™˜ë“¤ (ê°€ì¥ í—·ê°ˆë¦¬ëŠ” íŒŒíŠ¸!)\n3. **Lumps & Bumps:** ë‚­ì¢…(Cysts)ê³¼ ë©ì–´ë¦¬ë“¤\n4. **Malignancies:** ì•” (The scary stuff)\n5. **Functional Pain:** ê¸°ëŠ¥ì  í†µì¦\n---\n## 2. Pediatric Vulvovaginal Issues (ì†Œì•„ ì™¸ìŒë¶€ ë¬¸ì œ) ğŸ‘¶\n### ğŸ…°ï¸ Labial Adhesions (ì†ŒìŒìˆœ ìœ ì°©)\n- **Target Patient:** ì‚¬ì¶˜ê¸° ì´ì „ ì—¬ì•„ (Pre-pubertal girls, ì£¼ë¡œ 2~3ì„¸).\n- **Cause:** **Low Estrogen (ì €ì—ìŠ¤íŠ¸ë¡œê²)**.\n    - ì¶œìƒ ì§í›„ì—” ì—„ë§ˆì˜ ì—ìŠ¤íŠ¸ë¡œê²ì´ ë‚¨ì•„ìˆì§€ë§Œ, ê·¸ê²Œ ë–¨ì–´ì§€ë©´ì„œ í”¼ë¶€ê°€ ì–‡ì•„ì§€ê³  ëˆì í•´ì ¸ì„œ ë¶™ì–´ë²„ë¦¼(Physiological trough). í•´ë¶€í•™ì  ê¸°í˜•ì´ ì•„ë‹˜!\n- **Management (ì¹˜ë£Œ):**\n    - ì†Œë³€ ì˜ ë³´ê³  í†µì¦ ì—†ìŒ (Asymptomatic) â†’ **Observe (ê´€ì°°)**. ì‚¬ì¶˜ê¸° ë˜ì–´ í˜¸ë¥´ëª¬ ë‚˜ì˜¤ë©´ ì €ì ˆë¡œ ë–¨ì–´ì§.\n    - ì¦ìƒ ìˆìŒ (UTI, ë‹¹ê¸°ëŠ” ëŠë‚Œ ë“±) â†’ **Topical Estrogen Cream (êµ­ì†Œ ì—ìŠ¤íŠ¸ë¡œê² í¬ë¦¼)**. í”¼ë¶€ë¥¼ ë‘ê»ê²Œ ë§Œë“¤ì–´ ë¶„ë¦¬ì‹œí‚´.\n### ğŸ…±ï¸ Foreign Body (ì´ë¬¼ì§ˆ) ğŸ§»\n- **Scenario:** ì™¸ìƒ(Trauma) ì—†ì´ ëƒ„ìƒˆë‚˜ëŠ” ê³ ë¦„ ê°™ì€ ë¶„ë¹„ë¬¼(Foul-smelling, purulent discharge) í˜¹ì€ ì¶œí˜ˆì´ ìˆëŠ” ì•„ì´.\n- **Culprit:** ê°€ì¥ í”í•œ ì›ì¸ì€ **Toilet Paper (íœ´ì§€ ë­‰ì¹˜)**. ë’¤ì²˜ë¦¬ê°€ ì„œíˆ´ëŸ¬ì„œ ì§ˆ ì•ˆì— ë‚¨ìŒ.\n- **Management:**\n    - â˜… **NO Speculum (ì§ˆê²½ ê¸ˆì§€):** ì•„ì´ì—ê²Œ íŠ¸ë¼ìš°ë§ˆì™€ í†µì¦ì„ ì¤Œ.\n    - **Warm Fluid Irrigation (ë”°ëœ»í•œ ì‹ì—¼ìˆ˜ ì„¸ì²™):** ì”»ì–´ë‚´ê¸° ì‹œë„.\n    - ê·¸ë˜ë„ ì•ˆ ë˜ë©´? â†’ ë§ˆì·¨ í•˜ì— ë‚´ì‹œê²½(Vaginoscopy under sedation).\n- **Visual Buzzwords (ì‹œê°ì  ë‹¨ì„œ):**\n    - ğŸ© **Donut-shaped mass:** Urethral Prolapse (ìš”ë„ íƒˆì¶œ) â†’ Benign (ì–‘ì„±).\n    - ğŸ‡ **Grape-like mass:** **Sarcoma Botryoides (Rhabdomyosarcoma)** â†’ **Cancer (ì•”)**. ì¦‰ì‹œ í™•ì¸ í•„ìš”!\n---\n## 3. Itch & Pain: The Lichens (ê°€ë ¤ì›€ê³¼ í†µì¦) ğŸŒµ","subject":"LM_gyne 2 2f446f2986ee8041a277d7ea0baa58c8","page_title":"LM_gyne 2 2f446f2986ee8041a277d7ea0baa58c8","episode":"LM_gyne 2 2f446f2986ee8041a277d7ea0baa58c8","section_path":["LM_gyne 2 2f446f2986ee8041a277d7ea0baa58c8"],"source_doc_id":"LM_gyne 2 2f446f2986ee8041a277d7ea0baa58c8","source_page":null,"source_anchor":"LM_gyne 2 2f446f2986ee8041a277d7ea0baa58c8-111"}
{"chunk_type":"transcript_chunk","text":"ì´ë¦„ì´ ë¹„ìŠ·í•´ì„œ ê°€ì¥ í—·ê°ˆë¦¬ëŠ” íŒŒíŠ¸ì…ë‹ˆë‹¤. **ìœ„ì¹˜(Location)**ê°€ í•µì‹¬ì…ë‹ˆë‹¤!\n| êµ¬ë¶„ | **Lichen Sclerosus (LS)** | **Lichen Planus (LP)** |\n| --- | --- | --- |\n| **ì£¼ìš” ì¦ìƒ** | **Intense Pruritus (ê·¹ì‹¬í•œ ê°€ë ¤ì›€)** | Pain, Burning, Pruritus |\n| **ìœ„ì¹˜ (Key)** | â˜… **Outside Only (Vulva)**. ì§ˆ ë‚´ë¶€ëŠ” ì¹¨ë²” ì•ˆ í•¨. | **Inside (Vagina) â˜…  AND Outside**. |\n| **í”¼ë¶€ ì†Œê²¬** | \"Cigarette paper\" (ì–‡ì€ ë‹´ë°° ì¢…ì´), ì£¼ë¦„ì§, 8ì ëª¨ì–‘(Figure-of-8 around anus). í•´ë¶€í•™ì  êµ¬ì¡° ì†Œì‹¤(Resorption)- ë§‰í˜..\nì ë§‰ ì¹¨ë²”ì•ˆí•¨!!!!! â˜…  | **Wickham striae** (ë ˆì´ìŠ¤ ê°™ì€ í°ìƒ‰ í…Œë‘ë¦¬), ì§ˆ ë‚´ë¶€ì˜ ë¶‰ì€ ë¯¸ë€(Erosion). |\n| **ë™ë°˜ ì§ˆí™˜** | - | **Oral ulcers/Gingivitis** (ì…ì•ˆë„ í™•ì¸ í•„ìˆ˜!) |\n| **Risk** | **SCC (í¸í‰ì„¸í¬ì•”) ìœ„í—˜ ì¦ê°€** | - |\n| **ì§„ë‹¨** | **Biopsy (ìƒê²€)** - ì•” ë°°ì œ í•„ìˆ˜ | Biopsy |\n| **ì¹˜ë£Œ** | **High Potency Topical Steroids (Clobetasol)** | Steroids |\n> ğŸ’¡ Mental Model:\n> \n> - **SCLEROSUS S CAN OUTSIDE:** CAN for cancer OUTSIDE for ì ë§‰ì¹¨ë²”ì•ˆí•¨.\n> - **Planus:** \"Pla IN\" í”Œë ˆ IN ì•ˆìª½ ì ë§‰ ì¹¨ë²”.\n---\n## 4. Lumps & Bumps: Cysts (ë‚­ì¢…) ğŸˆ\nìœ„ì¹˜(Clock position)ë¥¼ ê¸°ì–µí•˜ì„¸ìš”! ì§ˆ ì…êµ¬ë¥¼ ì‹œê³„ë¼ê³  ìƒê°í•©ì‹œë‹¤.\n### ğŸ•“ Bartholin Gland Cyst (ë°”ë¥´í†¨ë¦° ë‚­ì¢…)\n- **Location:** **4ì‹œ, 8ì‹œ ë°©í–¥** (Labia base).\n- **Management:**\n    - ì¦ìƒ ì—†ìŒ (Asymptomatic) â†’ **Do nothing**.\n    - í†µì¦/ê°ì—¼ (Abscess, Painful) â†’ **I&D (ì ˆê°œë°°ë†) + â˜…Word Catheter**.\n        - ë‹¨ìˆœíˆ ì§¸ê¸°ë§Œ í•˜ë©´(Simple slit) 24ì‹œê°„ ë‚´ì— ê²‰ì— í”¼ë¶€ë§Œ ë‹¤ì‹œ ë¶™ì–´ì„œ ì¬ë°œí•¨.\n        - **Word Catheter:** ì‘ì€ í’ì„ ì„ ë„£ì–´ 4~6ì£¼ê°„ ë‘ì–´ì„œ ìƒˆë¡œìš´ ë°°ì¶œ í†µë¡œ(Epithelialized tract)ë¥¼ ë§Œë“¤ì–´ì¤˜ì•¼ í•¨.\n    - ë°˜ë³µ ì¬ë°œ ì‹œ â†’ **Marsupialization** (ì£¼ë¨¸ë‹ˆ ë§Œë“¤ê¸° ìˆ˜ìˆ ).\n### ğŸ•™ Skene's Gland Cyst (ìŠ¤í‚¨ìƒ˜ ë‚­ì¢…)\n- **Location:** **10ì‹œ, 2ì‹œ ë°©í–¥** (Periurethral, ìš”ë„ ì£¼ë³€).\n### ğŸ’§ Urethral Diverticulum (ìš”ë„ ê²Œì‹¤)\n- **Mechanism:** ìš”ë„ ë²½ì— ì£¼ë¨¸ë‹ˆê°€ ìƒê²¨ ì†Œë³€ì´ ê³ ì˜€ë‹¤ê°€ ë‚˜ì¤‘ì— í˜ëŸ¬ë‚˜ì˜´.\n- **Symptom:** **Post-void Dribble** (ì†Œë³€ ë‹¤ ë³´ê³  ì¼ì–´ë‚¬ëŠ”ë° íŒ¬í‹° ì ì‹¬).\n    - **The 3 D's:** Dysuria(ë°°ë‡¨í†µ), Dyspareunia(ì„±êµí†µ), **Dribbling(ì†Œë³€ í˜ë¦¼)**.\n- **Exam:** ì§ˆ ì•ë²½(Anterior vaginal wall)ì—ì„œ ë©ì–´ë¦¬ê°€ ë§Œì ¸ì§.\n- **Diagnosis:** **MRI**.\n---\n## 5. Malignancies (ì•…ì„± ì¢…ì–‘) ğŸ¦€\n### ğŸ…°ï¸ Vulvar Cancer (ì™¸ìŒë¶€ì•”)\n- **Type:** ì£¼ë¡œ **Squamous Cell Carcinoma (SCC)**.\n- **Risk Factors:**\n    1. **HPV 16, 18** (ì Šì€ ì—¬ì„±, í¡ì—°ì).\n    2. **Lichen Sclerosus** (ê³ ë ¹ ì—¬ì„±, ë§Œì„± ì—¼ì¦).\n- **Presentation:** ë‚«ì§€ ì•ŠëŠ” ê°€ë ¤ì›€(Itch that won't go away), ê¶¤ì–‘(Ulcer), í”Œë¼í¬(Plaque).\n- **Management:** â˜… **Biopsy (Punch Biopsy)** is Mandatory! (ìŠ¤í…Œë¡œì´ë“œ í¬ë¦¼ ë°”ë¥´ê¸° ì „ì— ì•”ë¶€í„° ë°°ì œí•  ê²ƒ).\n### ğŸ…±ï¸ Vaginal Cancer (ì§ˆì•”)\në‘ ê°€ì§€ ì£¼ìš” ìœ í˜•ê³¼ \"ì´ì›ƒ ë™ë„¤\"ë¥¼ ê¸°ì–µí•˜ì„¸ìš”.\n| ìœ í˜• | **Squamous Cell Carcinoma** | **Clear Cell Adenocarcinoma** |\n| --- | --- | --- |\n| **í™˜ìêµ°** | ì£¼ë¡œ íê²½ í›„ ì—¬ì„± (Older) | **ì Šì€ ì—¬ì„± (Young)** |\n| **ìœ„ì¹˜** | ì§ˆ ìƒë¶€ 1/3, í›„ë²½ (Posterior) | ì§ˆ ì•ë²½ (Anterior wall) |\n| **Risk Factor** | HPV, Smoking | â˜… **DES (Diethylstilbestrol) Exposure in utero** (ì—„ë§ˆê°€ ì„ì‹  ì¤‘ ë³µìš©) |\n| **íŠ¹ì§•** | ê°€ì¥ í”í•¨ | DES í‚¤ì›Œë“œ ë‚˜ì˜¤ë©´ ë¬´ì¡°ê±´ ì´ê±°! |","subject":"LM_gyne 2 2f446f2986ee8041a277d7ea0baa58c8","page_title":"LM_gyne 2 2f446f2986ee8041a277d7ea0baa58c8","episode":"LM_gyne 2 2f446f2986ee8041a277d7ea0baa58c8","section_path":["LM_gyne 2 2f446f2986ee8041a277d7ea0baa58c8"],"source_doc_id":"LM_gyne 2 2f446f2986ee8041a277d7ea0baa58c8","source_page":null,"source_anchor":"LM_gyne 2 2f446f2986ee8041a277d7ea0baa58c8-131"}
{"chunk_type":"transcript_chunk","text":"---\n## 6. Functional Pain (ê¸°ëŠ¥ì  í†µì¦) âš¡\n### ğŸ§± Vaginismus (Genito-Pelvic Pain/Penetration Disorder)\n- **Symptom:** \"Hitting a wall\" (ë²½ì— ë¶€ë”ªíˆëŠ” ëŠë‚Œ). ì‚½ì… ì‹œë„ ì‹œ ë¶ˆìˆ˜ì˜ì ì¸ ê·¼ìœ¡ ê²½ë ¨(Involuntary spasm).\n- **Cause:** ì‹¬ë¦¬ì  ë¶ˆì•ˆ(Anxiety), í†µì¦ì— ëŒ€í•œ ë‘ë ¤ì›€.\n- **Treatment:** ìˆ˜ìˆ  ì•„ë‹˜!\n    - **Desensitization (ê°ê° ì™„í™”)**: Dilators (í™•ì¥ê¸°) ì‚¬ìš©.\n    - Pelvic Floor PT (ê³¨ë°˜ì € ë¬¼ë¦¬ì¹˜ë£Œ).\n### ğŸ”¥ Vulvodynia (ì™¸ìŒë¶€ í†µì¦ ì¦í›„êµ°)\n- **Symptom:** ê²‰ë³´ê¸°ì—” ì •ìƒì¸ë°, ì‚´ì§ë§Œ ë‹¿ì•„ë„ ì•„í”” (Pain to superficial touch).\n- **Test:** **Q-tip test** (ë©´ë´‰ìœ¼ë¡œ í†¡ ê±´ë“œë¦¬ë©´ ì†ŒìŠ¤ë¼ì¹˜ê²Œ ë†€ëŒ).\n- **Treatment:** Amitriptyline, Gabapentin (ì‹ ê²½í†µ ì•½ë¬¼), ê³¨ë°˜ì € ë¬¼ë¦¬ì¹˜ë£Œ.\n---\n## ğŸš€ Rapid Fire Recap (Must-Know Summary)\nì‹œí—˜ ì§ì „ ì´ê²ƒë§Œì€ ê¼­ ê¸°ì–µí•˜ì„¸ìš”!\n1. **3ì„¸ ì—¬ì•„ + Fused Labia:** ì›ì¸ì€ **Low Estrogen**. ì¹˜ë£ŒëŠ” ì¦ìƒ ì—†ìœ¼ë©´ ê´€ì°°, ìˆìœ¼ë©´ **Estrogen cream**.\n2. **4ì„¸ ì—¬ì•„ + Foul discharge:** ì›ì¸ì€ **Toilet paper**. ì¹˜ë£ŒëŠ” **Irrigation** (Speculum ê¸ˆì§€!).\n3. **Post-menopausal + Itching + White skin:** **Lichen Sclerosus**. ì§ˆ ë‚´ë¶€ëŠ” ê¹¨ë—í•¨(Outside only). **Biopsy** í•„ìˆ˜!\n4. **4 o'clock Cyst:** **Bartholin Gland Cyst**. í†µì¦ ìˆìœ¼ë©´ **I&D + Word Catheter**.\n5. **Post-void Dribble:** **Urethral Diverticulum**. ì§„ë‹¨ì€ **MRI**.\n6. **Grape-like mass in child:** **Sarcoma Botryoides**.\n7. **Young woman + Vaginal Cancer (Anterior wall):** **DES exposure** (Clear Cell Adenocarcinoma).\n8. **Donut-shaped mass in child:** **Urethral Prolapse** (Benign).\n> ğŸ’¡ Tutor's Closing Note:\n\"Don't dismiss the chronic itch. Biopsy it. Remember, horses not zebras, but distinguish the white patches!\" (ê°€ë ¤ì›€ì¦ ë¬´ì‹œí•˜ì§€ ë§ê³  ìƒê²€í•˜ì„¸ìš”. í”í•œ ê±¸ ë¨¼ì € ìƒê°í•˜ë˜, í°ìƒ‰ ë°˜ì ë“¤ì˜ ì°¨ì´ëŠ” í™•ì‹¤íˆ êµ¬ë¶„í•´ì•¼ í•©ë‹ˆë‹¤!) Good luck with your prep! ğŸ‘Š\n>\n# ğŸ§ USMLE Step 2 High Yield: Gynecology - Developmental Disorders & Anatomical Defects\n## ğŸ“ 1. Verification (0:00~0:30 Dictation)\n\"Okay, let's unpack this. Today isn't just about reviewing medical facts. We are on a very specific mission. We are taking a deep dive into the high yield world of USMLE Step 2 gynecology. But we're skipping the basics. We are not doing 'what is a period'. No. We are going straight for the curveballs. Exactly. We're targeting those, you know, tricky clinical vignettes where one or two details completely change the diagnosis.\"\n---\n## 1. Introduction: The Mission ğŸ¯\nì´ ê°•ì˜ëŠ” ë‹¨ìˆœí•œ ì˜í•™ì  ì‚¬ì‹¤ ë‚˜ì—´ì´ ì•„ë‹Œ, **USMLE Step 2 CK** ì‹œí—˜ì—ì„œ ê³ ë“ì ì„ ë°›ê¸° ìœ„í•œ \"High Yield\" í¬ì¸íŠ¸ë“¤ì„ ì§šì–´ì¤ë‹ˆë‹¤. ê¸°ë³¸ì ì¸ ìƒë¦¬í•™ë³´ë‹¤ëŠ”, ë‹¨ í•œë‘ ê°œì˜ ë””í…Œì¼ë¡œ ì§„ë‹¨ì´ ì™„ì „íˆ ë°”ë€ŒëŠ” **Tricky Clinical Vignette(ì„ìƒ ì‹œë‚˜ë¦¬ì˜¤)**ë¥¼ ê³µëµí•˜ëŠ” ë° ì§‘ì¤‘í•©ë‹ˆë‹¤.\nì£¼ìš” í† í”½ì€ í¬ê²Œ ë‘ ê°€ì§€ì…ë‹ˆë‹¤:\n1. **Anatomical Defects:** íŠ¹íˆ Urethral Diverticulum (ìš”ë„ ê²Œì‹¤)\n2. **Disorders of Sex Development (DSD):** ì„± ë°œë‹¬ ì¥ì•  (ìœ ì „í•™ ë° í˜¸ë¥´ëª¬)\n---","subject":"LM_gyne 2 2f446f2986ee8041a277d7ea0baa58c8","page_title":"LM_gyne 2 2f446f2986ee8041a277d7ea0baa58c8","episode":"LM_gyne 2 2f446f2986ee8041a277d7ea0baa58c8","section_path":["LM_gyne 2 2f446f2986ee8041a277d7ea0baa58c8"],"source_doc_id":"LM_gyne 2 2f446f2986ee8041a277d7ea0baa58c8","source_page":null,"source_anchor":"LM_gyne 2 2f446f2986ee8041a277d7ea0baa58c8-151"}
{"chunk_type":"transcript_chunk","text":"## 2. Anatomical Oddity: Urethral Diverticulum (ìš”ë„ ê²Œì‹¤) ğŸ’§\nê°•ì˜ì—ì„œëŠ” ì´ ì§ˆí™˜ì„ ë°°ê´€ ë¬¸ì œ(Plumbing issue)ì— ë¹„ìœ í•˜ë©°, ì‹œí—˜ì—ì„œ ìì£¼ ë†“ì¹˜ëŠ” í¬ì¸íŠ¸ë¼ê³  ê°•ì¡°í•©ë‹ˆë‹¤.\n### ğŸ’¡ ê°œë… (Concept)\n- **ì •ì˜:** ìš”ë„ ì ë§‰(Urethral mucosa)ì´ ì£¼ë³€ ì¡°ì§ìœ¼ë¡œ ë¹„ì •ìƒì ìœ¼ë¡œ ì£¼ë¨¸ë‹ˆì²˜ëŸ¼ íŠ€ì–´ë‚˜ì˜¨ ê²ƒ(Localized outpouching).\n- **ì›ì¸:** ë³´í†µ ê°ì—¼(Infection)ì—ì„œ ì‹œì‘ë¨. ìš”ë„ ì£¼ìœ„ ë¶„ë¹„ì„ (Periurethral gland) ê°ì—¼ â†’ ë†ì–‘(Abscess) í˜•ì„± â†’ í„°ì§ â†’ ì˜êµ¬ì ì¸ ì£¼ë¨¸ë‹ˆ(Pocket) í˜•ì„±.\n- **ë¬¸ì œì :** ì´ ì£¼ë¨¸ë‹ˆ(Pocket)ì— ì†Œë³€ì´ë‚˜ ì°Œêº¼ê¸°(Debris)ê°€ ê³ ì´ê²Œ ë¨.\n### ğŸš© ì„ìƒì  íŠ¹ì§• (Clinical Presentation) - The Classic Triad (3D) â˜…\nì‹œí—˜ì—ì„œ í™˜ìê°€ ë‹¤ìŒê³¼ ê°™ì€ ì¦ìƒì„ í˜¸ì†Œí•˜ë©´ ì¦‰ì‹œ ì˜ì‹¬í•´ì•¼ í•©ë‹ˆë‹¤.\n1. **Dysuria:** ë°°ë‡¨í†µ\n2. **Dyspareunia:** ì„±êµí†µ\n3. **â˜… Post-void Dribbling (ë°°ë‡¨ í›„ ì ì ):** ê°€ì¥ ê²°ì •ì ì¸ ë‹¨ì„œ(Specific clue). ì†Œë³€ì„ ë‹¤ ë´¤ë‹¤ê³  ìƒê°í–ˆëŠ”ë°, ì¼ì–´ì„œë©´ ì£¼ë¨¸ë‹ˆì— ê³ ì—¬ìˆë˜ ì†Œë³€ì´ ì°”ë” ìƒˆì–´ ë‚˜ì˜¤ëŠ” í˜„ìƒ.\n### ğŸ©º ì§„ë‹¨ ë° ì¹˜ë£Œ (Workup & Management)\n- **ì‹ ì²´ ì§„ì°°:** ì§ˆ ì „ë²½(Anterior vaginal wall)ì—ì„œ ì••í†µì´ ìˆëŠ” ë©ì–´ë¦¬(Tender mass)ê°€ ë§Œì ¸ì§. ì••ë°• ì‹œ ê³ ë¦„(Pus)ì´ë‚˜ ë¶„ë¹„ë¬¼ì´ ë‚˜ì˜¬ ìˆ˜ ìˆìŒ.\n- **í™•ì§„ ê²€ì‚¬ (Gold Standard):** **MRI of the Pelvis** â˜… (CT ì•„ë‹˜!)\n- **ì¹˜ë£Œ:** **Surgical Excision** (ìˆ˜ìˆ ì  ì œê±°). ê°ì—¼ì˜ ê³ ë¦¬ë¥¼ ëŠê¸° ìœ„í•´ ì£¼ë¨¸ë‹ˆë¥¼ ì œê±°í•´ì•¼ í•¨.\n---\n## 3. Disorders of Sex Development (DSD): The 3-Point Framework ğŸ§¬Â ê°€ / í„¸ / ì / ì§„\nì„± ë°œë‹¬ ì¥ì•  ë¬¸ì œëŠ” ë§¤ìš° í˜¼ë€ìŠ¤ëŸ½ì§€ë§Œ, ë‹¤ìŒ **3ê°€ì§€ ë³€ìˆ˜**ë§Œ í™•ì¸í•˜ë©´ í¼ì¦ì„ í’€ ìˆ˜ ìˆìŠµë‹ˆë‹¤.\n> ğŸ—ï¸ The 3 Variables Checklist: ê°€ í„¸ ì ì§„\n> \n> 1. **Karyotype:** XX vs XY?\n> 2. **Gonads & Secondary Characteristics:** ê°€ìŠ´(Breast - Estrogen), í„¸(Pubic hair - Androgen)ì´ ìˆëŠ”ê°€?\n> 3. **Uterus:** ìê¶ì´ ìˆëŠ”ê°€, ì—†ëŠ”ê°€?\n---\n## 4. Scenario A: Turner Syndrome (í„°ë„ˆ ì¦í›„êµ°) ğŸ¦‹\n<aside>\nğŸ’¡\níƒ€ë°”ì½”\níƒ€: í„°ë„ˆì‹ ë“œë¡¬\në°”: bicuspid AV\nì½”: coarctation","subject":"LM_gyne 2 2f446f2986ee8041a277d7ea0baa58c8","page_title":"LM_gyne 2 2f446f2986ee8041a277d7ea0baa58c8","episode":"LM_gyne 2 2f446f2986ee8041a277d7ea0baa58c8","section_path":["LM_gyne 2 2f446f2986ee8041a277d7ea0baa58c8"],"source_doc_id":"LM_gyne 2 2f446f2986ee8041a277d7ea0baa58c8","source_page":null,"source_anchor":"LM_gyne 2 2f446f2986ee8041a277d7ea0baa58c8-171"}
{"chunk_type":"transcript_chunk","text":"</aside>\n- **Karyotype:** **45, XO** (X ì—¼ìƒ‰ì²´ í•˜ë‚˜ê°€ ë¶€ë¶„ì  ë˜ëŠ” ì™„ì „íˆ ì†Œì‹¤)\n- \n- **í•µì‹¬ ë³‘íƒœìƒë¦¬:** Ovarian Failure (Streak ovaries). ë‚œì†Œê°€ ê¸°ëŠ¥ì„ ì•ˆ í•˜ë¯€ë¡œ ì—ìŠ¤íŠ¸ë¡œê²ì´ ë‚®ê³ , í”¼ë“œë°± ì‘ìš©ìœ¼ë¡œ **FSH/LHê°€ ë§¤ìš° ë†’ìŒ** (Hypergonadotropic hypogonadism).\n### ğŸš© ì„ìƒ ì–‘ìƒ\n- Primary Amenorrhea (ì›ë°œì„± ë¬´ì›”ê²½)\n- Short stature (ì €ì‹ ì¥), Webbed neck (ìµìƒê²½), Broad chest (ë„“ì€ ê°€ìŠ´)\n### â˜… Next Step in Management (ì‹œí—˜ ì¶œì œ í¬ì¸íŠ¸)\në‹¨ìˆœ ì§„ë‹¨ì—ì„œ ëë‚˜ì§€ ì•Šê³ , **ë™ë°˜ ì§ˆí™˜(Comorbidity) ìŠ¤í¬ë¦¬ë‹**ì„ ë¬»ìŠµë‹ˆë‹¤. ì „ì‹  ì›Œí¬ì—…ì´ í•„ìˆ˜ì…ë‹ˆë‹¤.\n- â¤ï¸ **Heart:** ëŒ€ë™ë§¥ ì¶•ì°©(Coarctation of the aorta), ì´ì²¨íŒ ëŒ€ë™ë§¥íŒ(Bicuspid aortic valve) â†’ **Echocardiogram or Cardiac MRI** í•„ìˆ˜! (ëŒ€ë™ë§¥ ë°•ë¦¬ ìœ„í—˜) + 4ì§€ í˜ˆì••.\n- ğŸ© **Kidney:** ë§êµ½ ì‹ ì¥(Horseshoe kidney) â†’ Renal Ultrasound.\n- ğŸ¦‹ **Thyroid:** ìê°€ë©´ì—­ ê°‘ìƒì„  ì§ˆí™˜ (Hypothyroidism) ìœ„í—˜.\n- ğŸ‘‚/ğŸ‘ï¸: ì²­ë ¥ ë° ì‹œë ¥ ë¬¸ì œ.\n- ğŸ¦´ **Bone:** ì—ìŠ¤íŠ¸ë¡œê² ë¶€ì¡±ìœ¼ë¡œ ì¸í•œ ê³¨ë‹¤ê³µì¦(Osteoporosis) ìœ„í—˜.\n---\n## 5. Scenario B: Aromatase Deficiency ğŸŒ¸âŒ\n- **Karyotype:** **46, XX**\n- **í•µì‹¬ ë³‘íƒœìƒë¦¬:** Androgenì„ Estrogenìœ¼ë¡œ ë°”ê¿”ì£¼ëŠ” íš¨ì†Œ(Aromatase)ê°€ ì—†ìŒ. â†’ **Testosterone ê³¼ë‹¤, Estrogen ë¶€ì¡±.**\n### ğŸš© ì„ìƒ ì–‘ìƒ (The \"Tell\"): ì—„ë§ˆë„ ë³€í•´\n- **â˜… Maternal Virilization (ì—„ë§ˆì˜ ë‚¨ì„±ì™€):** ì„ì‹  ì¤‘ íƒœì•„ì˜ ì•ˆë“œë¡œê²ì´ íƒœë°˜ì„ ë„˜ì–´ì™€ ì—„ë§ˆì—ê²Œ ì˜í–¥ì„ ì¤Œ. (ì—„ë§ˆê°€ ëª©ì†Œë¦¬ê°€ êµµì–´ì§€ê³  í„¸ì´ ë‚¨). **ê°€ì¥ ê²°ì •ì ì¸ ë‹¨ì„œ!**\n- **ì¶œìƒ ì‹œ:** Ambiguous genitalia (ëª¨í˜¸í•œ ì„±ê¸°).\n- **ì‚¬ì¶˜ê¸°:** Primary Amenorrhea, ë‚¨ì„±ì™€(Virilization) ì§„í–‰.\n- **íŠ¹ì§•:** í‚¤ê°€ í¼ (Tall stature). ì—ìŠ¤íŠ¸ë¡œê²ì´ ì—†ì–´ì„œ ì„±ì¥íŒì´ ë‹«íˆì§€ ì•ŠìŒ.\n---\n## 6. Scenario C: 5-Alpha Reductase Deficiency ğŸ§”\n- **Karyotype:** **46, XY**\n- **í•µì‹¬ ë³‘íƒœìƒë¦¬:** Testosteroneì€ ì •ìƒì´ë‚˜, ì´ë¥¼ ê°•ë ¥í•œ **DHT(Dihydrotestosterone)**ë¡œ ë°”ê¾¸ëŠ” íš¨ì†Œê°€ ì—†ìŒ. DHTëŠ” ì™¸ë¶€ ìƒì‹ê¸°(External plumbing) í˜•ì„±ì— í•„ìˆ˜ì .\n### ğŸš© ì„ìƒ ì–‘ìƒ: ì‚¬ì¶˜ê¸°\n- **ì¶œìƒ ì‹œ:** Ambiguous genitalia ë˜ëŠ” ì—¬ì„±ì²˜ëŸ¼ ë³´ì„ (Blind pouch).\n- **ì‚¬ì¶˜ê¸° (The Plot Twist):** ì‚¬ì¶˜ê¸°ì— í…ŒìŠ¤í† ìŠ¤í…Œë¡ ì´ í­ë°œì ìœ¼ë¡œ ì¦ê°€í•˜ë©´ì„œ ë’¤ëŠ¦ê²Œ ë‚¨ì„±ì™€ê°€ ì§„í–‰ë¨.\n    - ëª©ì†Œë¦¬ê°€ êµµì–´ì§, ê·¼ìœ¡ ë°œë‹¬, **clitomegaly,** **ì„±ê¸°(Phallus)ê°€ ì»¤ì§**.\n    - ìœ ë°© ë°œë‹¬ ì—†ìŒ (No breast).\n    - ì¼ëª… **\"Guevedoces\"** (12ì‚´ì— ê³ ì¶”ê°€ ìƒê¸´ë‹¤ëŠ” ëœ»).\n---\n## 7. The Great Debate: No Uterus? (ìê¶ì´ ì—†ì„ ë•Œ) ğŸš«\ní™˜ìê°€ ê²‰ë³´ê¸°ì—” ì—¬ì„±(Phenotypically female)ì¸ë° **ìê¶ì´ ì—†ëŠ”(No Uterus)** ê²½ìš°, ë‹¤ìŒ ë‘ ê°€ì§€ë¥¼ ê°ë³„í•˜ëŠ” ê²ƒì´ í•µì‹¬ì…ë‹ˆë‹¤. ê¸°ì¤€ì€ **Pubic Hair(ìŒëª¨)** ì…ë‹ˆë‹¤.","subject":"LM_gyne 2 2f446f2986ee8041a277d7ea0baa58c8","page_title":"LM_gyne 2 2f446f2986ee8041a277d7ea0baa58c8","episode":"LM_gyne 2 2f446f2986ee8041a277d7ea0baa58c8","section_path":["LM_gyne 2 2f446f2986ee8041a277d7ea0baa58c8"],"source_doc_id":"LM_gyne 2 2f446f2986ee8041a277d7ea0baa58c8","source_page":null,"source_anchor":"LM_gyne 2 2f446f2986ee8041a277d7ea0baa58c8-191"}
{"chunk_type":"transcript_chunk","text":"### ğŸ†š Mullerian Agenesis vs. Androgen Insensitivity Syndrome (AIS)\n| êµ¬ë¶„ | **Mullerian Agenesis (MRKH)** | **Androgen Insensitivity Syndrome (AIS)** |\n| --- | --- | --- |\n| **í•µí˜• (Karyotype)** | **46, XX** | **46, XY** |\n| **ë³‘íƒœìƒë¦¬** | ë®¬ëŸ¬ê´€ ë°œë‹¬ ì‹¤íŒ¨ (ë‚œì†ŒëŠ” ì •ìƒ) | ì•ˆë“œë¡œê² ìˆ˜ìš©ì²´ ê³ ì¥ (Testosterone ë†’ìœ¼ë‚˜ ë°˜ì‘ ì•ˆ í•¨) |\n| **ê°€ìŠ´ (Breasts)** | ë°œë‹¬í•¨ (ë‚œì†Œì—ì„œ Estrogen ë‚˜ì˜´) | ë°œë‹¬í•¨ (Testosteroneì´ ë§ì´ˆì—ì„œ Estrogenìœ¼ë¡œ ë³€í™˜ë¨) |\n| **í„¸ (Pubic Hair)** | **ì •ìƒ (Normal)** âœ… | **ì—†ìŒ (Absent/Sparse)** âŒ (ìˆ˜ìš©ì²´ ê³ ì¥) |\n| **ë‚´ë¶€ ì¥ê¸°** | ë‚œì†Œ ìˆìŒ, ìê¶/ìƒë¶€ ì§ˆ ì—†ìŒ | ì •ì†Œ(Testes) ìˆìŒ (ì ë³µ), ìê¶ ì—†ìŒ |\n| **ê´€ë ¨ ì§ˆí™˜** | **Renal abnormalities** (ì‹ ì¥ ê¸°í˜•) | ê³ í™˜ ì•” ìœ„í—˜ (ì„±ì„  ì œê±°ìˆ  í•„ìš”) |\n> â˜… í•µì‹¬ ê°ë³„ì :\n> \n> - **Mullerian Agenesis:** 46,XX + í„¸ ìˆìŒ + ì‹ ì¥(ì½©íŒ¥) í™•ì¸ í•„ìš”.\n> - **AIS:** 46,XY + í„¸ ì—†ìŒ(ë§¤ëˆí•¨) + ê³ í™˜ ì œê±° í•„ìš”.\n---\n## âš¡ Rapid Fire Recap (High Yield Summary)\nê°•ì˜ ë§ˆì§€ë§‰ì— ì •ë¦¬ëœ ì‹œí—˜ ì§ì „ ë°˜ë“œì‹œ ê¸°ì–µí•´ì•¼ í•  \"Scenario Match\"ì…ë‹ˆë‹¤.\n1. **Dysuria + Pain during Sex + Post-void Dribbling (ì˜¤ì¤Œ ì°”ë”)**\n    - ğŸ‘‰ **Urethral Diverticulum (ìš”ë„ ê²Œì‹¤)**.\n    - ğŸ‘‰ ì§„ë‹¨: **Pelvic MRI**.\n2. **Short Stature + Webbed Neck + High FSH**\n    - ğŸ‘‰ **Turner Syndrome (45,XO)**.\n    - ğŸ‘‰ í•„ìˆ˜ ê²€ì‚¬: **Heart (Aorta check)** & **Kidneys**.\n3. **Virilized Mom (ì„ì‹  ì¤‘ ì—„ë§ˆê°€ ë‚¨ì„±ì™€) + Baby with Ambiguous Genitalia**\n    - ğŸ‘‰ **Aromatase Deficiency** (Can't make Estrogen).\n4. **Girl at birth -> Becomes a Man at Puberty (Clitoris grows into penis)**\n    - ğŸ‘‰ **5-Alpha Reductase Deficiency** (No DHT).\n5. **Normal Breasts + No Uterus + Normal Pubic Hair**\n    - ğŸ‘‰ **Mullerian Agenesis (46,XX)**.\n    - ğŸ‘‰ í•„ìˆ˜ ê²€ì‚¬: **Renal Ultrasound** (Renal agenesis í™•ì¸).\n6. **Normal Breasts + No Uterus + NO Pubic Hair (Scant hair)**\n    - ğŸ‘‰ **Androgen Insensitivity Syndrome (AIS, 46,XY)**.\n    - ğŸ‘‰ íŠ¹ì§•: í…ŒìŠ¤í† ìŠ¤í…Œë¡  ìˆ˜ì¹˜ëŠ” ë†’ìŒ.\n**Verification (0:00~0:30 ë°›ì•„ì“°ê¸°)**\n> \"Welcome back to the deep dive. Today we're uh doing something a little bit different and frankly I'm really excited about it. We are tackling a beast of a topic but we're doing it with a very specific mission in mind. That's right. Usually we take a broad look at a subject but today we are laser focused. We're looking at male reproductive health but specifically through the lens of the USMLE Step 2 exam.\"\n>\n---\n# ğŸ©º Deep Dive: Male Reproductive Health for USMLE Step 2 CK\nì´ ê°•ì˜ë¡ì€ íŒŸìºìŠ¤íŠ¸ ë‚´ìš©ì„ ë°”íƒ•ìœ¼ë¡œ **USMLE Step 2 CK** ì‹œí—˜ì„ ì¤€ë¹„í•˜ëŠ” í•™ìƒë“¤ì„ ìœ„í•´ ì‘ì„±ë˜ì—ˆìŠµë‹ˆë‹¤. ë‹¨ìˆœ ì•”ê¸°ê°€ ì•„ë‹Œ **ì„ìƒì  ì‹œë‚˜ë¦¬ì˜¤(Vignette)**ì™€ **ì˜ì‚¬ê²°ì • ë…¼ë¦¬(Logic)**ì— ì´ˆì ì„ ë§ì¶”ê³  ìˆìŠµë‹ˆë‹¤.\n## 1. Introduction: The Exam Mindset ğŸ§ \n- **ëª©í‘œ:** êµê³¼ì„œì ì¸ ì‚¬ì‹¤ ë‚˜ì—´ì´ ì•„ë‹Œ, ì‹œí—˜ì¥ì—ì„œ í™˜ìê°€ ê±¸ì–´ ë“¤ì–´ì™”ì„ ë•Œì˜ **Script**ì™€ **Algorithm**ì„ êµ¬ì¶•í•˜ëŠ” ê²ƒ.\n- **ì ‘ê·¼ë²•:** ë‹¨ìˆœ ì•”ê¸°ë³´ë‹¤ëŠ” \"Immediate fork in the road(ì¦‰ê°ì ì¸ ê°ˆë¦¼ê¸¸)\"ë¥¼ ì°¾ì•„ë‚´ì–´ ì§„ë‹¨ê³¼ ì²˜ì¹˜ë¥¼ ê²°ì •í•˜ëŠ” ë…¼ë¦¬ì  íë¦„ì´ ì¤‘ìš”í•©ë‹ˆë‹¤.\n---\n## 2. The Male Breast (ë‚¨ì„± ìœ ë°© ì§ˆí™˜) ğŸ’\nì‹œí—˜ì—ì„œ ê°€ì¥ í”í•˜ê²Œ ì¶œì œë˜ëŠ” ì‹œë‚˜ë¦¬ì˜¤ ì¤‘ í•˜ë‚˜ì…ë‹ˆë‹¤. \"ì´ê²Œ ì•”ì¸ê°€ìš”, ì•„ë‹ˆë©´ ê·¸ëƒ¥ ì§€ë°©ì¸ê°€ìš”?\"ë¥¼ êµ¬ë³„í•˜ëŠ” ê²ƒì´ í•µì‹¬ì…ë‹ˆë‹¤.\n### ğŸš© Clinical Scenario & Differentiation\n- **í™˜ì:** ì‚¬ì¶˜ê¸° ì†Œë…„(13ì„¸) í˜¹ì€ ë‚˜ì´ ë“  ë‚¨ì„±.\n- **ì´‰ì§„(Tactile)ì´ í•µì‹¬:**\n    - **Pseudogynecomastia (ê°€ì„± ì—¬ìœ ì¦):** ë¹„ë§Œê³¼ ê´€ë ¨. ë¶€ë“œëŸ½ê³  ì§€ë°© ì¡°ì§ì´ ë§Œì ¸ì§(Fatty tissue). ì „ì‹  ë¹„ë§Œê³¼ ì¼ì¹˜í•¨.\n    - **True Gynecomastia (ì§„ì„± ì—¬ìœ ì¦):** ìœ ë‘(Nipple) ë°”ë¡œ ì•„ë˜ì— **ë‹¨ë‹¨í•˜ê³  ê³ ë¬´ ê°™ì€ ë””ìŠ¤í¬(Rubbery disc)**ê°€ ë§Œì ¸ì§. â˜… **ìœ„ì¹˜ì™€ ëŒ€ì¹­ì„±**ì´ ì¤‘ìš” (ì£¼ë¡œ ì–‘ì¸¡ì„±, ìœ ë‘ ì¤‘ì•™ CENTRAL â˜… ).\n### ğŸ” Physiologic vs. Pathologic Causes","subject":"LM_gyne 2 2f446f2986ee8041a277d7ea0baa58c8","page_title":"LM_gyne 2 2f446f2986ee8041a277d7ea0baa58c8","episode":"LM_gyne 2 2f446f2986ee8041a277d7ea0baa58c8","section_path":["LM_gyne 2 2f446f2986ee8041a277d7ea0baa58c8"],"source_doc_id":"LM_gyne 2 2f446f2986ee8041a277d7ea0baa58c8","source_page":null,"source_anchor":"LM_gyne 2 2f446f2986ee8041a277d7ea0baa58c8-211"}
{"chunk_type":"transcript_chunk","text":"ì‹œí—˜ì—ì„œëŠ” **\"ì–¸ì œ ì•ˆì‹¬ì‹œì¼œì•¼ í•˜ëŠ”ê°€(Reassurance)\"**ì™€ **\"ì–¸ì œ ê²€ì‚¬ë¥¼ í•´ì•¼ í•˜ëŠ”ê°€\"**ë¥¼ ë¬»ìŠµë‹ˆë‹¤.\n| ìœ í˜• | ì„¤ëª… ë° ì›ì¸ | ê´€ë¦¬ (Management) |\n| --- | --- | --- |\n| **Physiologic** (ìƒë¦¬ì ) | **ì›ì¸:** Puberty(ì‚¬ì¶˜ê¸°) & Aging(ë…¸í™”).\ní…ŒìŠ¤í† ìŠ¤í…Œë¡ ê³¼ ì—ìŠ¤íŠ¸ë¡œê²ì˜ ì¼ì‹œì  ë¶ˆê· í˜•(Imbalance). | â˜… **Observation & Reassurance.** (ì¡°ì§ê²€ì‚¬ë‚˜ ì˜ìƒì´¬ì˜ ê¸ˆì§€ âŒ) 1ë…„ ë‚´ ìì—° ì†Œì‹¤ë¨. |\n| **Pathologic** (ë³‘ë¦¬ì ) | **ì•½ë¬¼:** Spironolactone, Cimetidine, Ketoconazole (Anti-androgenic effects).\n**ì§ˆí™˜:** Cirrhosis(ê°„ê²½ë³€ - ì—ìŠ¤íŠ¸ë¡œê² ëŒ€ì‚¬ ì €í•˜), Hypogonadism. | ì›ì¸ ì•½ë¬¼ ì¤‘ë‹¨ ë˜ëŠ” ê¸°ì € ì§ˆí™˜ ì¹˜ë£Œ. |\n- spironolactone â†’ eplerenoneìœ¼ë¡œ êµì²´\n- Tea tree oil, lavendar oil..\n- hyperthyroidism: SHBG â†‘ â†’ testosteroneê³¼ì˜ ê²°í•©ë ¥ â†‘ â†’ free T â†“\n- renal failure: estrogen ë°°ì¶œ â†“\n- Work up: HCG, LH, FSH ì¸¡ì •\n    - hcg â†‘ â†’ testicular cancer â†’ testicular ultrasound\n    - high LH low T â†’ r/o Kleinfelter\n    - low LH low T â†’ pituitary suppressed\n    - â†‘ â†‘ â†‘ estridiol â†’ leydig cell tumor?\n### âš ï¸ Male Breast Cancer (ë‚¨ì„± ìœ ë°©ì•”)\n- **íŠ¹ì§•:** í¸ì¸¡ì„±(**Unilateral**), ì¤‘ì‹¬ì—ì„œ ë²—ì–´ë‚¨(**Eccentric**), ë”±ë”±í•¨(Rock hard), ê³ ì •ë¨(Fixed), í”¼ë¶€ ë”¤í”Œë§(Peau d'orange), ìœ ë‘ ë¶„ë¹„ë¬¼(íŠ¹íˆ í˜ˆì„±). ì—¬ìë‘ ë¹„ìŠ·í•œ ëŠë‚Œ.\n- **ìœ ì „:** **BRCA2** ìœ ì „ì ë³€ì´ì™€ ê°•ë ¥í•œ ì—°ê´€ì„±. â˜…, Kleinfelter risk â†‘ (chronic estrogen â†‘ )\n- **Workup:** Mammogram(ìœ ë°©ì´¬ì˜ìˆ ) â†’ Core Needle Biopsy.\n---\n## 3. Hypogonadism (ì„±ì„ ê¸°ëŠ¥ì €í•˜ì¦) ğŸ“‰\ní˜¸ë¥´ëª¬ ì¶•(Axis)ì„ ì´í•´í•˜ëŠ” ê²ƒì´ ì¤‘ìš”í•©ë‹ˆë‹¤. **Thermostat(ì‹œìƒí•˜ë¶€/ë‡Œí•˜ìˆ˜ì²´)**ì™€ **Furnace(ê³ í™˜)**ì˜ ë¹„ìœ ë¥¼ ì‚¬ìš©í•˜ì„¸ìš”.\n### ğŸ§ª Diagnostic Framework (The Feedback Loop)\n- **Primary Hypogonadism (ê³ í™˜ ë¬¸ì œ):** Furnaceê°€ ê³ ì¥ë‚¨. ë‡Œ(Thermostat)ëŠ” ì‹ í˜¸ë¥¼ ê³„ì† ë³´ëƒ„.\n    - Labs: **Low Testosterone, High LH/FSH.**\n    - â˜… **Klinefelter Syndrome (XXY):** í‚¤ê°€ í¬ê³ , ì—¬ì„±í˜• ìœ ë°©, ì‘ì€ ê³ í™˜.\n- **Secondary Hypogonadism (ë‡Œ ë¬¸ì œ):** Thermostatê°€ ê³ ì¥ë‚¨. ê³ í™˜ì€ ë©€ì©¡í•œë° ì‹ í˜¸ê°€ ì•ˆ ì˜´.\n    - Labs: **Low Testosterone, Low or Inappropriately Normal LH/FSH.**\n### ğŸš© Key Secondary Causes (Must-Knows)\n1. **Opioids (ì˜¤í”¼ì˜¤ì´ë“œ):** ë§Œì„± í†µì¦ í™˜ì. GnRH ë° LH ë¶„ë¹„ë¥¼ ì–µì œí•˜ì—¬ Axisë¥¼ ì…§ë‹¤ìš´ ì‹œí‚´. â˜…\n2. **Hemochromatosis (í˜ˆìƒ‰ì†Œì¹¨ì°©ì¦):** \"Bronze Diabetes\". ë‡Œí•˜ìˆ˜ì²´ì— ì² ë¶„ì´ ì¹¨ì°©ë˜ì–´ ì„¸í¬ë¥¼ íŒŒê´´í•¨.\n3. **Prolactinoma:** ë†’ì€ í”„ë¡œë½í‹´ì€ GnRHë¥¼ ì–µì œí•¨. (ì„±ìš• ê°í‡´, ì‹œì•¼ ì¥ì•  ë™ë°˜ ê°€ëŠ¥).\n4. **Anabolic Steroids (ì•„ë‚˜ë³¼ë¦­ ìŠ¤í…Œë¡œì´ë“œ):** ì™¸ë¶€ì—ì„œ ì•ˆë“œë¡œê²ì´ ë“¤ì–´ì˜¤ë‹ˆ ìì²´ ìƒì‚° ì¤‘ë‹¨.\n    - íŠ¹ì§•: ê·¼ìœ¡ì§ˆ ë‚¨ì„± + **ì‘ì€ ê³ í™˜(Testicular Atrophy)** + ë¶ˆì„. â˜…\n5. **Systemic Illness/Weight Loss:** ìƒì¡´ ëª¨ë“œë¡œ ì¸í•´ ìƒì‹ ê¸°ëŠ¥ ì°¨ë‹¨.\n---\n## 4. The Prostate (ì „ë¦½ì„ ) ğŸŒ°\n### ğŸ”¥ Prostatitis (ì „ë¦½ì„ ì—¼) - Safety Warning!\n- **Acute Bacterial Prostatitis:**\n    - ì¦ìƒ: ê³ ì—´, ì˜¤í•œ, íšŒìŒë¶€ í†µì¦, ë°°ë‡¨ ê³¤ë€.\n        - DRE(ì§ì¥ìˆ˜ì§€ê²€ì‚¬): **Boggy(ë¬¼ë í•˜ê³ ), Exquisitely Tender(ê·¹ì‹¬í•œ í†µì¦).**\n        - â˜… **ê¸ˆê¸°ì‚¬í•­(Contraindication):** **Vigorous Prostate Massage ê¸ˆì§€** (Bacteremia/Septic shock ìœ ë°œ ê°€ëŠ¥). **Foley Catheter ì‚½ì… ê¸ˆì§€** (ì—¼ì¦ ë¶€ìœ„ ìê·¹, Suprapubic catheter ê¶Œì¥).\n    - ì¹˜ë£Œ: í•­ìƒì œ (E.coli íƒ€ê²Ÿ, Fluoroquinolones ë“±) ì¥ê¸° ë³µìš©.\n- **Chronic Prostatitis:** ë°˜ë³µë˜ëŠ” UTI(ìš”ë¡œê°ì—¼), ê°™ì€ ê· ì£¼ ì¬ë°œ.\n- **Chronic Pelvic Pain Syndrome (CPPS):** í†µì¦ì€ ìˆìœ¼ë‚˜ ë°°ì–‘ê²€ì‚¬(Culture)ëŠ” ìŒì„±(Sterile).\n### ğŸš½ BPH (Benign Prostatic Hyperplasia)\n- **ìœ„ì¹˜:** Transition Zone (ìš”ë„ë¥¼ ê°ì‹¸ê³  ìˆìŒ â†’ ì¦ìƒ ìœ ë°œ).\n- **ì•½ë¬¼ ì¹˜ë£Œ ë¹„êµ (Board Favorite):**\n    - **Alpha-blockers (ì˜ˆ: Tamsulosin):** ìš”ë„ ê´„ì•½ê·¼ ì´ì™„. íš¨ê³¼ ë¹ ë¦„. ë¶€ì‘ìš©: ê¸°ë¦½ì„± ì €í˜ˆì••(Orthostatic hypotension).\n    - **5-Alpha Reductase Inhibitors (ì˜ˆ: Finasteride):** DHT ìƒì„± ì°¨ë‹¨. ì „ë¦½ì„  í¬ê¸° ìì²´ë¥¼ ì¤„ì„. íš¨ê³¼ ëŠë¦¼(ìˆ˜ê°œì›”). ë¶€ì‘ìš©: ì„±ê¸°ëŠ¥ ì¥ì• .\n### ğŸ¦€ Prostate Cancer\n- **ìœ„ì¹˜:** Peripheral Zone (DREë¡œ ë§Œì ¸ì§). ì†Œë³€ì¦ìƒì€ ì ìŒ.\n- **íŠ¹ì§•:** Nodular, Firm, Asymmetric.\n- **ì „ì´:** **Bone metastasis (Osteoblastic - ë¼ˆ ìƒì„±ì„±).** í—ˆë¦¬ í†µì¦ í˜¸ì†Œ ì‹œ ì˜ì‹¬.\n- **Screening:** PSA ê²€ì‚¬ëŠ” ë…¼ë€ì´ ìˆìŒ. í™˜ìì™€ì˜ **Shared Decision Making(ê³µë™ ì˜ì‚¬ê²°ì •)**ì´ ì •ë‹µ.","subject":"LM_gyne 2 2f446f2986ee8041a277d7ea0baa58c8","page_title":"LM_gyne 2 2f446f2986ee8041a277d7ea0baa58c8","episode":"LM_gyne 2 2f446f2986ee8041a277d7ea0baa58c8","section_path":["LM_gyne 2 2f446f2986ee8041a277d7ea0baa58c8"],"source_doc_id":"LM_gyne 2 2f446f2986ee8041a277d7ea0baa58c8","source_page":null,"source_anchor":"LM_gyne 2 2f446f2986ee8041a277d7ea0baa58c8-231"}
{"chunk_type":"transcript_chunk","text":"---\n## 5. Scrotal & Testicular Pathology ğŸ¥š\n### ğŸ”¦ Scrotal Masses (ë¹›ì„ ë¹„ì¶°ë³´ë¼!)\n- **Hydrocele (ìŒë‚­ìˆ˜ì¢…):** **Transillumination (ë¹› íˆ¬ê³¼) ì–‘ì„±.** ì†Œì•„ëŠ” ê´€ì°°(Observation), ì„±ì¸ì€ ì›ì¸ ê°ë³„.\n- **Varicocele (ì •ê³„ì •ë§¥ë¥˜):** \"Bag of worms (ë²Œë ˆ ì£¼ë¨¸ë‹ˆ)\" ëŠë‚Œ. ëˆ„ìš°ë©´ ì‚¬ë¼ì§.\n    - **Left side:** í”í•¨ (í•´ë¶€í•™ì  êµ¬ì¡°ìƒ Left Renal Veinì´ ê¸¸ê³  ëˆŒë¦¬ê¸° ì‰¬ì›€).\n    - â˜… **Right side Varicocele:** **Red Flag!** (IVCë¡œ ë°”ë¡œ ì—°ê²°ë˜ë¯€ë¡œ ë§‰íˆê¸° ì–´ë ¤ì›€). **Retroperitoneal Mass (ì˜ˆ: Renal Cell Carcinoma)**ê°€ IVCë¥¼ ëˆ„ë¥´ê³  ìˆëŠ”ì§€ CT ìŠ¤ìº” ë“± ì •ë°€ ê²€ì‚¬ í•„ìš”.\n    - ëˆ„ì› ì„ë•Œ ì‚¬ë¼ì§€ì§€ì•ŠëŠ”ë‹¤ë©´ ì§€ì†ì ìœ¼ë¡œ ë§‰ê³  ìˆëŠ” mass, thrombosisë¥¼ ì‹œì‚¬\n    - ê²°ë¡ : Right side or ëˆ„ì›Œë„ ì§€ì†ë¨ â†’ ì •ë°€í‰ê°€í•„ìš”\n    - ë”°ëœ»í•¨ â†’ fertility issue, testicular atrophy\n### ğŸŒ‘ Testicular Cancer (ê³ í™˜ì•”)\n- **Scenario:** 15~35ì„¸ ì Šì€ ë‚¨ì„±. **í†µì¦ ì—†ëŠ”(Painless) ë‹¨ë‹¨í•œ ê³ í˜• ì¢…ê´´(Solid mass).**\n- **ì§„ë‹¨ ê·œì¹™:** **ë¹› íˆ¬ê³¼ ì•ˆ ë¨(Does NOT transilluminate).**\n    - â˜… **ê¸ˆê¸°ì‚¬í•­:** **Trans-scrotal Biopsy ì ˆëŒ€ ê¸ˆì§€!** (ì•”ì„¸í¬ê°€ ìŒë‚­ ë¦¼í”„ê´€ìœ¼ë¡œ í¼ì§ˆ ìˆ˜ ìˆìŒ).\n- **ì²˜ì¹˜:** **Radical Inguinal Orchiectomy** (ì„œí˜œë¶€ ì ˆê°œë¡œ ê³ í™˜ ì ì¶œ).\n- **Tumor Markers:**\n    - Seminoma: ë§ˆì»¤ ìŒì„±ì¼ ìˆ˜ ìˆìŒ. **AFP negative.** ì˜ˆí›„ ì¢‹ìŒ\n    - Non-seminoma: **AFP**, **beta-hCG** ìƒìŠ¹.\n- **Risk factors:** ê³ í™˜ì ë³µì¦\n---\n## 6. The Penis & Urethra ğŸ†\n### ğŸš‘ Emergencies & Structural Issues\n- **Erectile Dysfunction (ED):**\n    - **Psychogenic:** **Nocturnal tumescence (Morning wood) ìˆìŒ.** ìƒí™©ì— ë”°ë¼ ë‹¤ë¦„.\n    - **Organic:** ì„œì„œíˆ ì§„í–‰. ë‹¹ë‡¨, ê³ í˜ˆì•• ë“± í˜ˆê´€/ì‹ ê²½ ë¬¸ì œ.\n    - **Peyronie's Disease:** Tunica albugineaì˜ ì„¬ìœ í™”(Fibrous plaque). ë°œê¸° ì‹œ **íœ˜ì–´ì§(Curvature)**.\n- **Penile Fracture:**\n    - Scenario: ì„±ê´€ê³„ ì¤‘ \"ëš(Snap)\" ì†Œë¦¬ í›„ ë°œê¸° ì†Œì‹¤.\n    - ì§•í›„: **\"Eggplant Deformity\"** (ê°€ì§€ì²˜ëŸ¼ ë³´ë¼ìƒ‰ìœ¼ë¡œ ë¶“ê³  íœ¨).\n    - ì²˜ì¹˜: **Surgical Emergency.** (ì¦‰ì‹œ ìˆ˜ìˆ ).\n- **Priapism:** 4ì‹œê°„ ì´ìƒ ì§€ì†ë˜ëŠ” ë°œê¸°. Ischemic injury ìœ„í—˜. Sickle Cell Disease, Trazodone ë“±ì´ ì›ì¸.\n- **Phimosis vs. Paraphimosis:**\n    - Phimosis: í¬í”¼ê°€ ì•ˆ ë²—ê²¨ì§ (ëœ ì‘ê¸‰).\n    - â˜… **Paraphimosis:** ë²—ê²¨ì§„ í¬í”¼ê°€ ê·€ë‘ ë’¤ì— ë¼ì–´ì„œ ì•ˆ ëŒì•„ì˜´. **Emergency!** (ì§€í˜ˆëŒ€ íš¨ê³¼ë¡œ ê´´ì‚¬ ìœ„í—˜).\n- **Hypospadias (ìš”ë„í•˜ì—´):** ìš”ë„ ì…êµ¬ê°€ ì•„ë˜ìª½(Ventral)ì— ìœ„ì¹˜. â˜… **Circumcision(í¬ê²½ìˆ˜ìˆ ) ê¸ˆì§€!** (ë‚¨ëŠ” í¬í”¼ë¥¼ ì¬ê±´ ìˆ˜ìˆ ì— ì¨ì•¼ í•¨).\n### ğŸ”¥ Urethritis (ìš”ë„ì—¼)\n- **ì¦ìƒ:** ë°°ë‡¨í†µ(Dysuria), ìš”ë„ ë¶„ë¹„ë¬¼.\n- **ì›ì¸ê·  & íŠ¹ì§•:**\n    - **Gonorrhea (ì„ì§ˆ):** Purulent(ê³ ë¦„ ê°™ì€), Creamy discharge.\n    - **Chlamydia (í´ë¼ë¯¸ë””ì•„):** Watery(ë¬¼ ê°™ì€), íˆ¬ëª…í•œ ë¶„ë¹„ë¬¼.\n- **ì¹˜ë£Œ:** â˜… **Empiric Treatment for BOTH!** (ê²€ì‚¬ ê²°ê³¼ ë‚˜ì˜¤ê¸° ì „ì´ë¼ë„ ë‘˜ ë‹¤ ì»¤ë²„).\n    - **Ceftriaxone (IM) + Doxycycline (Oral).**\n    - **Trichomonas:** **Metronidazole**ë¡œ ì¹˜ë£Œ (í™˜ìì™€ íŒŒíŠ¸ë„ˆ ëª¨ë‘ ì¹˜ë£Œ).\n---","subject":"LM_gyne 2 2f446f2986ee8041a277d7ea0baa58c8","page_title":"LM_gyne 2 2f446f2986ee8041a277d7ea0baa58c8","episode":"LM_gyne 2 2f446f2986ee8041a277d7ea0baa58c8","section_path":["LM_gyne 2 2f446f2986ee8041a277d7ea0baa58c8"],"source_doc_id":"LM_gyne 2 2f446f2986ee8041a277d7ea0baa58c8","source_page":null,"source_anchor":"LM_gyne 2 2f446f2986ee8041a277d7ea0baa58c8-251"}
{"chunk_type":"recap_summary","text":"## âš¡ Rapid Fire Recap (Must-Know Summary)\nê°•ì˜ ë§ˆì§€ë§‰ì— ì–¸ê¸‰ëœ ì´ˆê³ ì† ìš”ì•½ì…ë‹ˆë‹¤.\n1. **Mass in 25M, painless, solid:** Testicular Cancer. **Tx:** Radical Inguinal Orchiectomy. (No Biopsy!).\n2. **Right-sided Varicocele:** Scan for abdominal malignancy (RCC).\n3. **Acute Prostatitis:** **No Foley, No Massage.**\n4. **BPH Meds:** Tamsulosin (Fast, Orthostatic hypo) vs. Finasteride (Slow, shrinks prostate).\n5. **Testicular Torsion:** Absent cremasteric reflex. **Surgical Emergency** (Detorsion + Orchiopexy both sides). *(ì˜¤ë””ì˜¤ ë³¸ë¬¸ì—ì„œëŠ” Torsionì´ ê¹Šê²Œ ë‹¤ë¤„ì§€ì§€ ì•Šì•˜ìœ¼ë‚˜ Recap íë¦„ìƒ ì¤‘ìš”í•˜ê²Œ ì–¸ê¸‰ë¨)*.\n6. **Gynecomastia in Puberty:** **Observe.** (Don't touch it).\n7. **Male Breast Cancer:** Hard, eccentric, **BRCA2**.\n8. **Penile Fracture:** \"Snap\" sound + Eggplant deformity = **Surgery.**","subject":"LM_gyne 2 2f446f2986ee8041a277d7ea0baa58c8","page_title":"LM_gyne 2 2f446f2986ee8041a277d7ea0baa58c8","episode":"LM_gyne 2 2f446f2986ee8041a277d7ea0baa58c8","section_path":["LM_gyne 2 2f446f2986ee8041a277d7ea0baa58c8"],"source_doc_id":"LM_gyne 2 2f446f2986ee8041a277d7ea0baa58c8","source_page":null,"source_anchor":"LM_gyne 2 2f446f2986ee8041a277d7ea0baa58c8-264"}
{"chunk_type":"transcript_chunk","text":"# Gyne\n| **ëŒ€ë¶„ë¥˜ (Origin)** | **ìƒì„¸ ê³„ë³´ (Lineage)** | **ì—¬ì„± ì¢…ì–‘ (Female)** | **ë‚¨ì„± ì¢…ì–‘ (Male)** | **í•µì‹¬ ì»¨í…ìŠ¤íŠ¸ (Context & Note)** |\n| --- | --- | --- | --- | --- |\n| **[A] Germ Cells** (ì”¨ì•—) ì• ê¸°ê°€ ë  ë†ˆë“¤ | **ë¯¸ë¶„í™”** (Primitive) | **Dysgerminoma** | **Seminoma** | ê°€ì¥ ê¸°ë³¸í˜•. ì„¸í¬ê°€ ë§‘ìŒ(Fried-egg). |\n|  | **ë°°ì•„ ë¶„í™”** (Embryo) | **Embryonal Ca** | **Embryonal Ca** | ê³µê²©ì , necrosis ì‹¬í•¨, ë‚¨ë…€ ê³µí†µ â˜… |\n|  | **ë‚œí™©ë‚­ ë¶„í™”** (Yolk Sac) | **Yolk Sac Tumor** | **Yolk Sac Tumor** | **AFP ìƒìŠ¹**, Schiller-Duval body (ë„ì‹œë½) |\n|  | **íƒœë°˜ ë¶„í™”** (Placenta) | **Choriocarcinoma** | **Choriocarcinoma** | **hCG í­ë°œ**, í˜ˆí–‰ì„± ì „ì´(í/ë‡Œ) â˜… |\n|  | **3ë°°ì—½ ë¶„í™”** (All 3 layers) | **Teratoma** | **Teratoma** | ì„±ìˆ™(ì–‘ì„±) vs ë¯¸ì„±ìˆ™(ì•…ì„±) êµ¬ë¶„ ì¤‘ìš” |\n| **[B] Sex Cord** (ì•ˆìª½ ì¼ê¾¼) | **ì—¬ì„±í–¥ ì¼ê¾¼** (Granulosa) | **Granulosa Cell Tumor** | - | **Estrogen â†‘**, Adult(íê²½í›„ì¶œí˜ˆ)/Juvenile(ì„±ì¡°ìˆ™ì¦) |\n|  | **ë‚¨ì„±í–¥ ì¼ê¾¼** (Sertoli) | - | **Sertoli Cell Tumor** | ëŒ€ê°œ ë¬´ì¦ìƒ, ë§¤ìš° ë“œë¬¾ |\n|  | **í˜¼í•©/ì ì¬ë ¥** (Mixed) | **Sertoli-Leydig Tumor** | - | **ì—¬ì„±ì—ì„œ ë‚¨ì„±í™”(Virilization)** ë°œìƒ â˜… |\n| **[C] Stromal Cells** (ë°”ê¹¥ìª½ í™)\nstromaê°€ í˜¸ë¥´ëª¬ ìê·¹ë°›ê³  thecaë‚˜ leydigë¡œ ë³€í•œë‹¤. | **ì—¬ì„±í–¥ í™** (Theca) | **Thecoma / Fibroma** | - | Meigs syndrome (Fibroma), ê³ í˜• ë©ì–´ë¦¬\nThecomaì§€ë§Œ ì—ìŠ¤íŠ¸ë¡œê²ì„ ë‚´ë¿œìŒ (ì˜ì™¸â€¦) |\n|  | **ë‚¨ì„±í–¥ í™** (Leydig) | - | **Leydig Cell Tumor** | **Androgen â†‘**, **Reinke crystals** â˜… |\n|  | **ì„ì‹  íŠ¹ìˆ˜** (Follicle íŒ½ì°½)\nâ€ì„ì‹ í• ë•Œ hcgê°€ ë§ì€ ìƒí™©ì—ì„œ ë‚œì†Œì•ˆì— ë‹¤ë¥¸ follicleë“¤ì˜ theca cellë“¤ì´ ìê·¹ë°›ìŒ. ë¬¼ì„ ì—„ì²­ ë‚œí¬ì•ˆì— ìŸì•„ëƒ„â€ â†’ â€œCYSTâ€  | **Theca-Lutein Cyst** | - | **hCG ê³¼ë¶€í•˜**, ë‚œí¬ ë‚´ ìš”ë¦¬ì‚¬(Granulosa) ìˆìŒ â†’ **ì•ˆë“œë¡œê² ì ìŒ** â˜… |\n|  | **ì„ì‹  íŠ¹ìˆ˜** (Stroma ë­‰ì¹¨)\nâ€ì„ì‹  í›„ë°˜ë¶€ë•Œ ì›ì¸ë¯¸ìƒ í˜¸ë¥´ëª¬ ë¶ˆê· í˜•ìœ¼ë¡œ ê°€ë§Œíˆìˆë˜ stroma í•œìª½ êµ¬ì—­ì—ì„œ ê°‘ìê¸° ì„¸í¬ë“¤ì´ ë­‰ì¹˜ê³  í™©ì²´í™”(ë…¸ë—ê²Œ)ë˜ë©´ì„œ ì•ˆë“œë¡œê²ì„ ë‚´ë¿œìŒâ€ â†’ â€œí•œê³³ì—ì„œ ë­‰ì¹˜ë©´ì„œ ë‚œë¦¬ì¹¨â€ â†’ â€œLutâ€(í™©ì²´í™”ëœ) + oma (ë©ì–´ë¦¬0 | **Pregnancy Luteoma** | - | ê¸°ì§ˆ ë‚´ ìš”ë¦¬ì‚¬(Granulosa) ì—†ìŒ â†’ **ì•ˆë“œë¡œê² í­ë°œ(ì—„ë§ˆ ìˆ˜ì—¼)** â˜… |\nì—¬ì„±\n| **ê¸°ì› (Origin)** | **ì¢…ì–‘ ì´ë¦„** | **í•œ ì¤„ ëŠë‚Œ (Vibe)** | **ì–¸ì œ? (Timing)** | **í•µì‹¬ íŠ¹ì§• (Key Points)** |\n| --- | --- | --- | --- | --- |\n| **Germ Cell** (ë¯¸ë¶„í™”) | **Dysgerminoma** | \"ì›ì‹œ ì”¨ì•—ì˜ ìˆœìˆ˜í•œ ì¦ì‹\" | 10~20ëŒ€ (ì Šì€ ì¸µ) | ì—¬ìì˜ Seminoma, LDH ìƒìŠ¹, Fried egg ëª¨ì–‘ |\n| **Germ Cell** (ë°°ì•„ ë¶„í™”) | **Embryonal Ca.** | \"ì—¬ì„±ì—ê²Œë„ ìˆëŠ” í‰í­í•œ ì”¨ì•—ì•”\" | 10~20ëŒ€ (ë“œë¬¾) | **ë§¤ìš° ê³µê²©ì **, ì¶œí˜ˆ/ê´´ì‚¬ ì‹¬í•¨, hCG/AFP ìƒìŠ¹ ê°€ëŠ¥ |\n| **Germ Cell** (ê¸°íƒ€) | **Yolk Sac / Chorio** | \"ë„ì‹œë½(AFP)ê³¼ íƒœë°˜(hCG) ì½”ìŠ¤í”„ë ˆ\" | ì•„ë™~ì Šì€ ì¸µ | Yolk sacì€ AFP ìƒìŠ¹, ChorioëŠ” hCG ë¯¸ì¹œë“¯ì´ ìƒìŠ¹ |\n|  |  |  |  |  |\n| **Sex Cord** (ì•ˆìª½ ì¼ê¾¼) | **Granulosa Cell Tumor** | \"ìš”ë¦¬ì‚¬ì˜ í­ì£¼ (ì—ìŠ¤íŠ¸ë¡œê²)\" | **Adult: 50ëŒ€+** / **Juvenile: ì•„ë™** | **Adult: íê²½ í›„ ì¶œí˜ˆ**, **Juvenile: ì„±ì¡°ìˆ™ì¦**, Call-Exner body |\n| **Sex Cord** (ì•ˆìª½ ì¼ê¾¼) | **Sertoli-Leydig** | \"ì—¬ì ëª¸ì†ì˜ ë‚¨ì„± ì¼ê¾¼ ë°˜ë€\" â€œë‚¨ìì— ìˆì–´ì•¼í• ê²ƒë“¤ì´ì§€ë§Œ ìˆ¨ì–´ìˆë˜ê²ƒë“¤ì´ ë‚˜ì˜´..â€ | 20~30ëŒ€ | **Virilization (ë‚¨ì„±í™”)**, ì•ˆë“œë¡œê² ê³¼ë‹¤(ìˆ˜ì—¼, ëª©ì†Œë¦¬) |\n|  |  |  |  |  |\n| **Stroma** (ë°”ê¹¥ìª½ í™) | **Thecoma / Fibroma (**ì´ë¦„í•˜ê³  ë‹¤ë¥´ê²Œ ì—¬ì„±í˜¸ë¥´ëª¬ ë‚´ë¿œìŒ) | \"ê¸°ì§ˆ(Spindle cell)ì´ ë­‰ì¹œ ëŒ\" | íê²½ í›„ í”í•¨ | Meigs syndrome (ë³µìˆ˜, í‰ìˆ˜), ëŒ€ê°œ ì–‘ì„± ê³ í˜• ì¢…ì–‘.\n |\n|  |  |  |  |  |\n| **ì„ì‹  íŠ¹ìˆ˜** **(Follicle ë‚´)** | **Theca-Lutein Cyst** | \"hCG í­íƒ„ ë§ì€ í’ì„ \" | ì„ì‹  ì¤‘ (H-mole ë“±) | hCG ìê·¹ â†’ Theca ë¶€í’€ìŒ ë¬¼ì°¨ì˜¤ë¦„. ì–‘ìª½ë‚œì†Œì— follicle ë‘˜ë‹¤ ìˆìŒ.â†’ **ì˜†ì§‘ Granulosaê°€ ì—ìŠ¤íŠ¸ë¡œê²ìœ¼ë¡œ ìš”ë¦¬í•¨** â†’ **ë‚¨ì„±í™” ì ìŒ** â˜…\në¹„ë¡ í™©ì²´ ê¸°ì›ì€ ì•„ë‹ˆì§€ë§Œ hcg ìê·¹ (LHë‘ ë¹„ìŠ·)ì— ì˜í•´ í™©ì²´â€™í™”â€™ ë¨. |\n| **ì„ì‹  íŠ¹ìˆ˜** **(Stroma ë‚´)** | **Pregnancy Luteoma\n(oma: ë©ì–´ë¦¬)** | \"ê¸°ì§ˆì—ì„œ ìš”ë¦¬ì‚¬ ì—†ì´ ë­‰ì¹¨\" | ì„ì‹  í›„ê¸° | ê¸°ì§ˆ ì„¸í¬ê°€ í™©ì²´í™”ë˜ì–´ ë­‰ì¹˜ë©´ì„œ ë‚¨ì„±í˜¸ë¥´ëª¬ ë§Œë“œëŠ” thecaí™”ë¨.â†’ **ì£¼ë³€ì— Granulosa ì—†ìŒ** â†’ ì•ˆë“œë¡œê² ìƒìœ¼ë¡œ ì¨ â†’ **ë‚¨ì„±í™” ì‹¬í•¨** â˜… |\në‚¨ì„±\n| **ê¸°ì› (Origin)** | **ì¢…ì–‘ ì´ë¦„** | **í•œ ì¤„ ëŠë‚Œ (Vibe)** | **ì–¸ì œ? (Timing)** | **í•µì‹¬ íŠ¹ì§• (Key Points)** |\n| --- | --- | --- | --- | --- |\n| **Germ Cell** (ë¯¸ë¶„í™”) | **Seminoma** | \"ì •ì†Œì•”ì˜ ê°€ì¥ í”í•œ í‘œì¤€\" | 15~35ì„¸ (í™©ê¸ˆê¸°) | í†µì¦ ì—†ëŠ” ê³ í™˜ ë¹„ëŒ€, ì˜ˆí›„ ì•„ì£¼ ì¢‹ìŒ, ë°©ì‚¬ì„  ì¹˜ë£Œ êµ¿ |\n| **Germ Cell** (ë°°ì•„ ë¶„í™”) | **Embryonal Ca.** | \"íŒŒê´´ì ì¸ ë°°ì•„ ì„¸í¬ì˜ ìŠµê²©\" | 20~30ëŒ€ | í†µì¦ ë™ë°˜, ì „ì´ ë¹ ë¦„, GCT ì¤‘ ê°€ì¥ ì‚¬ë‚˜ìš´ ë†ˆ ì¤‘ í•˜ë‚˜ |\n| **Germ Cell** (ë‚œí™© ë¶„í™”) | **Yolk Sac Tumor** | \"ì–´ë¦°ì•„ì´ë“¤ì˜ AFP ê³µì¥\" | **3ì„¸ ë¯¸ë§Œ ì˜ì•„** | Schiller-Duval bodies, ì†Œì•„ ì •ì†Œì•” ì••ë„ì  1ìœ„ |\n| **Germ Cell** (íƒœë°˜ ë¶„í™”) | **Choriocarcinoma** | \"íƒœë°˜ì¸ ì²™ í˜ˆê´€ íƒ€ê³  ì „ì´\" | 20~30ëŒ€ | **hCG í­ë°œ**, í/ë‡Œë¡œ í˜ˆí–‰ì„± ì „ì´ ë¹ ë¦„ (Cannonball) |\n|  |  |  |  |  |\n| **Stroma** (ë°”ê¹¥ìª½ í™) | **Leydig Cell Tumor** | \"ìƒë‚¨ì ê¼¬ë§ˆë¥¼ ë§Œë“œëŠ” ì•”\" | ì „ ì—°ë ¹ | **Reinke crystals**, ì•ˆë“œë¡œê² ê³¼ë‹¤ (ì„±ì¡°ìˆ™ì¦) |\n|  |  |  |  |  |\n| **Sex Cord** (ì•ˆìª½ ì¼ê¾¼) | **Sertoli Cell Tumor** | \"ì •ì í‚¤ìš°ëŠ” ì¼ê¾¼ì˜ ì¹¨ë¬µ\" | ì „ ì—°ë ¹ | ëŒ€ê°œ ì–‘ì„±, í˜¸ë¥´ëª¬ ì¦ìƒ ë“œë¬¼ì–´ ìš°ì—°íˆ ë°œê²¬ |","subject":"Gyne 2f646f2986ee80f8b89eef6e8dc2f9f5","page_title":"Gyne 2f646f2986ee80f8b89eef6e8dc2f9f5","episode":"Gyne 2f646f2986ee80f8b89eef6e8dc2f9f5","section_path":["Gyne 2f646f2986ee80f8b89eef6e8dc2f9f5"],"source_doc_id":"Gyne 2f646f2986ee80f8b89eef6e8dc2f9f5","source_page":null,"source_anchor":"Gyne 2f646f2986ee80f8b89eef6e8dc2f9f5-1"}
{"chunk_type":"transcript_chunk","text":"# LM_obs1\n**0:00 ~ 0:30 Dictation (Verbatim Verification)**\n\"Welcome back to the deep dive. Today we are heading straight to the OB floors. And listen, I know exactly what you're thinking. Oh yeah. You're thinking about the high drama moments, the emergency C-sections, the shoulder dystocias, maybe some, you know, rare tropical disease that shows up in a question bank. The zebras. The zebras, but let me set a different scene. You're on the wards, it's 2 a.m., and you're just staring at a patient's labs or fetal monitor. Your ability to crush Step 2...\"\n---\n# ğŸ¤° OB Floor Survival Guide: Pregnancy Physiology & Common Scenarios\n## 1. Introduction: Understanding the Baseline\nê°•ì˜ëŠ” Step 2ì—ì„œ ì‚´ì•„ë‚¨ìœ¼ë ¤ë©´ í™”ë ¤í•œ \"zebra\" ì¼€ì´ìŠ¤ë³´ë‹¤ëŠ” **Normal Physiology**ë¥¼ ì™„ë²½í•˜ê²Œ ì´í•´í•´ì•¼ í•œë‹¤ëŠ” ì ì„ ê°•ì¡°í•˜ë©´ì„œ ì‹œì‘í•©ë‹ˆë‹¤. ì„ì‹  ì¤‘ ìƒë¦¬ëŠ” 9ê°œì›” ë™ì•ˆ ëª¨ë“  ì¥ê¸° ì‹œìŠ¤í…œì— ê°€í•´ì§€ëŠ” **Stress Test**ì™€ ê°™ìŠµë‹ˆë‹¤. \"Normal\"ì´ ë¬´ì—‡ì¸ì§€ ëª¨ë¥´ë©´ ë³‘ì ì¸ ìƒíƒœë¥¼ êµ¬ë¶„í•  ìˆ˜ ì—†ìŠµë‹ˆë‹¤.\n- **Pregnancy Physiology**: 9-month stress test for every organ system.\n- **The Trap**: ì„ì‹  ì¤‘ì—ëŠ” physiologyê°€ ê·¹ì ìœ¼ë¡œ ë³€í•˜ê¸° ë•Œë¬¸ì—, non-pregnant patient ê¸°ì¤€ìœ¼ë¡œëŠ” \"emergency\"ì¸ ìˆ˜ì¹˜ê°€ ì„ì‹ ë¶€ì—ê²ŒëŠ” ì •ìƒì¼ ìˆ˜ ìˆìŠµë‹ˆë‹¤.\n## 2. Renal Physiology: The Filtration System\nê°€ì¥ ë¨¼ì € ì‹ ì¥(Kidneys)ì˜ ë³€í™”ë¥¼ ë‹¤ë£¹ë‹ˆë‹¤.\n### ğŸŒŠ Hydronephrosis & Dilated Ureters\n- **Clinical Scenario**: Mid-second trimester ì‚°ëª¨ê°€ **Right flank fullness** ë˜ëŠ” mild painì„ í˜¸ì†Œí•¨. Fever (-), White count (-), Stones (-) ì¸ë°, Ultrasoundì—ì„œ **Mild Hydronephrosis**ê°€ ë³´ì„.\n- **Reaction**: í•™ìƒë“¤ì€ Obstructionì„ ì˜ì‹¬í•˜ê³  Urologyë¥¼ ë¶€ë¥´ë ¤ê³  í•˜ì§€ë§Œ, ì´ëŠ” **Physiological Trap**ì…ë‹ˆë‹¤.\n- **Mechanism**:\n    1. **Hormonal**: **Progesterone**ì´ smooth muscle relaxantë¡œ ì‘ìš©í•˜ì—¬ Ureterë¥¼ í™•ì¥ì‹œí‚¤ê³  ëŠë¦¬ê²Œ ë§Œë“­ë‹ˆë‹¤ (baggy and sluggish).\n    2. **Mechanical**: ì»¤ì§„ **Uterus** (íŠ¹íˆ Dextrorotation ê²½í–¥ì´ ìˆìŒ)ê°€ **Right Ureter**ë¥¼ ë¬¼ë¦¬ì ìœ¼ë¡œ ëˆ„ë¦…ë‹ˆë‹¤.\n- **Conclusion**: Infection ì§•í›„ê°€ ì—†ëŠ” **Mild Right-sided Hydronephrosis**ëŠ” ì„ì‹  ì¤‘ **Normal**ì…ë‹ˆë‹¤.\n### ğŸ§ª Glomerular Filtration Rate (GFR) & Creatinine\n- **Hemodynamics**: ì„ì‹  ì¤‘ì—ëŠ” Blood volumeê³¼ Cardiac outputì´ ì—„ì²­ë‚˜ê²Œ ì¦ê°€í•©ë‹ˆë‹¤.\n- **Result**: Kidneysê°€ \"hammered with flow\" ìƒíƒœê°€ ë˜ì–´ **GFRì´ 50% ì¦ê°€**í•©ë‹ˆë‹¤.\n- **Creatinine (Cr)**: GFRì´ ì¦ê°€í•˜ë¯€ë¡œ Crì€ í‰ì†Œë³´ë‹¤ ë” ë§ì´ ë°°ì„¤ë˜ì–´ ë–¨ì–´ì§‘ë‹ˆë‹¤.\n    - **Non-pregnant Normal**: Cr 1.0 ~ 1.1\n    - **Pregnant Normal**: Cr 0.4 ~ 0.8\n    - **ğŸš¨ RED FLAG**: ì„ì‹ ë¶€ì˜ Crì´ 1.0 ~ 1.1ì´ë¼ë©´, ì´ëŠ” ì¼ë°˜ì¸ì—ê²ŒëŠ” ì •ìƒì´ì§€ë§Œ ì„ì‹ ë¶€ì—ê²ŒëŠ” **Renal Insufficiency**ë¥¼ ì˜ë¯¸í•˜ëŠ” ë³‘ì ì¸ ìˆ˜ì¹˜ì…ë‹ˆë‹¤.\n| **Condition** | **Non-Pregnant Cr** | **Pregnant Cr** | **Status in Pregnancy** |\n| --- | --- | --- | --- |\n| Normal | 1.0 ~ 1.1 | 0.4 ~ 0.8 | **Physiologic** |\n| Renal Issue | > 1.2 | 1.0 ~ 1.1 | **Pathologic (Red Flag)** |\n## 3. Musculoskeletal Changes: The Back Pain Dilemma\nê°€ì¥ í”í•œ ë¶ˆë§Œ ì¤‘ í•˜ë‚˜ì¸ **Back Pain**ì— ëŒ€í•œ ì ‘ê·¼ë²•ì…ë‹ˆë‹¤.\n### ğŸ¦´ Lordosis & Mechanical Strain\n- **Clinical Scenario**: 30ì£¼ ì‚°ëª¨ê°€ í—ˆë¦¬ë¥¼ ì¡ê³  ë’¤ëš±ê±°ë¦¬ë©° ë“¤ì–´ì˜´(waddling). ê±·ê³  ë‚˜ë©´ ë‹¤ë¦¬ê°€ ì €ë¦¬ë‹¤ê³  í•˜ë©°, ë³¸ì¸ì€ **Herniated Disc**ë¼ê³  í™•ì‹ í•˜ê³  **MRI**ë¥¼ ìš”êµ¬í•¨.\n- **Physiology**:\n    1. **Center of Gravity Shift**: Uterusê°€ ì»¤ì§€ë©´ì„œ ë¬´ê²Œ ì¤‘ì‹¬ì´ ì•ìœ¼ë¡œ ì ë¦½ë‹ˆë‹¤. ë„˜ì–´ì§€ì§€ ì•Šìœ¼ë ¤ê³  ìƒì²´ë¥¼ ë’¤ë¡œ ì –íˆê²Œ ë˜ë©° **Lordosis (Swayback posture)**ê°€ ì‹¬í•´ì§‘ë‹ˆë‹¤.\n    2. **Hormonal**: **Progesterone**ê³¼ **Relaxin**ì´ ê´€ì ˆê³¼ ì¸ëŒ€ë¥¼ ëŠìŠ¨í•˜ê²Œ ë§Œë“­ë‹ˆë‹¤. (Sacroiliac joint, Pelvis ë“±)\n    3. **Muscle Weakness**: ë³µê·¼(Abdominal muscles)ì´ ëŠ˜ì–´ë‚˜ ì•½í•´ì§€ë©´ì„œ í—ˆë¦¬ë¥¼ ì§€ì§€í•´ì£¼ì§€ ëª»í•©ë‹ˆë‹¤.\n- **Key Question**: **MRIë¥¼ ì°ì–´ì•¼ í•˜ëŠ”ê°€?**\n    - **Answer**: **Absolutely NOT**. Typical painì—ëŠ” imagingì„ í•˜ì§€ ì•ŠìŠµë‹ˆë‹¤. ì˜¤ì§ \"Red flags\" (progressive neuro deficits ë“±)ê°€ ìˆì„ ë•Œë§Œ ê³ ë ¤í•©ë‹ˆë‹¤.\n- **Management**: **Conservative Management** (Reassurance, Low-heeled shoes, Back support, Massage, Heating pads). \"Suck it up\"ì´ë¼ê³  ë§í•˜ëŠ” ëŒ€ì‹  ìƒë¦¬í•™ì  ì›ì¸ì„ ì„¤ëª…í•˜ê³  ì•ˆì‹¬ì‹œí‚¤ëŠ” ê²ƒì´ ì¤‘ìš”í•©ë‹ˆë‹¤.\n## 4. Trauma & Blood Compatibility: Mixing Issues","subject":"LM_obs1 2f646f2986ee80d3a4e8c9b5ab8a0b12","page_title":"LM_obs1 2f646f2986ee80d3a4e8c9b5ab8a0b12","episode":"LM_obs1 2f646f2986ee80d3a4e8c9b5ab8a0b12","section_path":["LM_obs1 2f646f2986ee80d3a4e8c9b5ab8a0b12"],"source_doc_id":"LM_obs1 2f646f2986ee80d3a4e8c9b5ab8a0b12","source_page":null,"source_anchor":"LM_obs1 2f646f2986ee80d3a4e8c9b5ab8a0b12-1"}
{"chunk_type":"transcript_chunk","text":"ì„ì‹  ì¤‘ Traumaë‚˜ ì¶œí˜ˆ ì´ë²¤íŠ¸ ì‹œ ë°œìƒí•  ìˆ˜ ìˆëŠ” **Rh Incompatibility** ë¬¸ì œì…ë‹ˆë‹¤.\n### ğŸ©¸ Fetomaternal Hemorrhage\n- **Scenario**: **Rh-negative** ì‚°ëª¨ê°€ Trauma(ì°¨ ì‚¬ê³ , ë‚™ìƒ ë“±)ë¥¼ ê²ªìŒ. Fetal bloodê°€ Maternal circulationìœ¼ë¡œ ë„˜ì–´ê°ˆ ìœ„í—˜ì´ ìˆìŒ.\n- **Risk**: ì—„ë§ˆê°€ Fetal RBCì— ëŒ€í•´ Antibodyë¥¼ í˜•ì„±(Sensitization)í•˜ë©´ ë‹¤ìŒ ì„ì‹  ë•Œ íƒœì•„ë¥¼ ê³µê²©í•  ìˆ˜ ìˆìŠµë‹ˆë‹¤.\n- **Action**: **RhoGAM (Anti-D Immune Globulin)**ì„ íˆ¬ì—¬í•´ì•¼ í•©ë‹ˆë‹¤. í•˜ì§€ë§Œ **ì–¼ë§ˆë‚˜(Dose)** ì¤˜ì•¼ í•˜ëŠ”ì§€ê°€ ë¬¸ì œì…ë‹ˆë‹¤.\n### ğŸ”¬ Kleihauer-Betke (KB) Test\n- **Concept**: Maternal bloodì™€ Fetal bloodë¥¼ êµ¬ë¶„í•˜ëŠ” í…ŒìŠ¤íŠ¸ì…ë‹ˆë‹¤.\n- **Mechanism (Acid Elution)**:\n    - **Adult Hemoglobin (HbA)**: Acidì— ë¶ˆì•ˆì •í•˜ì—¬ ì”»ê²¨ ë‚˜ê°‘ë‹ˆë‹¤ â†’ \"Ghost cells\" (empty).\n    - **Fetal Hemoglobin (HbF)**: ì‚°ì†Œë¥¼ ëºì–´ì˜¤ê¸° ìœ„í•´ êµ¬ì¡°ê°€ ë” íŠ¼íŠ¼í•˜ê³  Acidì— ì €í•­ì„±ì´ ê°•í•©ë‹ˆë‹¤ â†’ **Bright Pink Cells**ë¡œ ë‚¨ìŠµë‹ˆë‹¤.\n- **Calculation**: ë‚¨ì•„ìˆëŠ” Pink cells (Fetal cells)ì˜ ë¹„ìœ¨ì„ ì„¸ì–´ ì¶œí˜ˆëŸ‰(Hemorrhage volume)ì„ ê³„ì‚°í•˜ê³ , ê·¸ì— ë§ì¶° **RhoGAM dose**ë¥¼ ê²°ì •í•©ë‹ˆë‹¤.\n    - Standard doseëŠ” ì•½ 30mLì˜ fetal bloodë¥¼ ì»¤ë²„í•©ë‹ˆë‹¤. KB test ê²°ê³¼ ì¶œí˜ˆì´ ë” ë§ìœ¼ë©´ ìš©ëŸ‰ì„ ëŠ˜ë ¤ì•¼ í•©ë‹ˆë‹¤.\n## 5. Oxytocin & ADH: The Structural Twins\n**Labor induction** ì¤‘ ë°œìƒí•  ìˆ˜ ìˆëŠ” ì˜ì™¸ì˜ ë¶€ì‘ìš©ì…ë‹ˆë‹¤.\n### ğŸ’§ Water Intoxication (Hyponatremia)\n- **Scenario**: ì‚°ëª¨ê°€ **High-dose Oxytocin**ìœ¼ë¡œ ìœ ë„ ë¶„ë§Œ ì¤‘. ê°‘ìê¸° í˜¼ë€ìŠ¤ëŸ¬ì›Œí•˜ê±°ë‚˜(confusion), ì‹¬í•˜ë©´ ë°œì‘(seizure)ì„ ì¼ìœ¼í‚´.\n- **Mechanism**: **Oxytocin**ì€ ë‡Œí•˜ìˆ˜ì²´ í›„ì—½(Posterior Pituitary)ì—ì„œ ë¶„ë¹„ë˜ëŠ” **ADH (Vasopressin)**ì™€ êµ¬ì¡°ì ìœ¼ë¡œ ë§¤ìš° ë¹„ìŠ·í•©ë‹ˆë‹¤ (\"Evolutionary Cousins\").\n- **Result**: ê³ ìš©ëŸ‰ì˜ Oxytocinì€ ì‹ ì¥ì—ì„œ ADHì²˜ëŸ¼ ì‘ìš©í•˜ì—¬ **Water Retention**ì„ ìœ ë°œí•©ë‹ˆë‹¤. ì´ëŠ” **Severe Hyponatremia**ì™€ Water intoxicationìœ¼ë¡œ ì´ì–´ì ¸ Seizureë¥¼ ì¼ìœ¼í‚¬ ìˆ˜ ìˆìŠµë‹ˆë‹¤.\n- **Lesson**: Oxytocinì„ ì“¸ ë•ŒëŠ” Fluid statusì™€ Electrolyteë¥¼ ì£¼ì˜ ê¹Šê²Œ ë´ì•¼ í•©ë‹ˆë‹¤.\n## 6. Amniotic Fluid: The Fetal Environment\nì–‘ìˆ˜ëŸ‰ì˜ ì´ìƒì€ íƒœì•„ë‚˜ ì‚°ëª¨ì˜ ìƒíƒœë¥¼ ë°˜ì˜í•˜ëŠ” ê±°ìš¸ì…ë‹ˆë‹¤.\n### â¬†ï¸ Polyhydramnios (Too much fluid)\n- **Definition**: ì–‘ìˆ˜ê°€ ë„ˆë¬´ ë§ì€ ìƒíƒœ.\n- **Mechanisms**:\n    1. **Swallowing Issue**: íƒœì•„ê°€ ì–‘ìˆ˜ë¥¼ ì‚¼í‚¤ì§€ ëª»í•¨ (ì˜ˆ: Esophageal Atresia, Anencephaly).\n    2. **High Output**: íƒœì•„ê°€ ì†Œë³€ì„ ë„ˆë¬´ ë§ì´ ë´„ (ì˜ˆ: Maternal Diabetes â†’ Fetal Hyperglycemia â†’ Polyuria).\n### â¬‡ï¸ Oligohydramnios (Too little fluid)\n- **Definition**: ì–‘ìˆ˜ê°€ ë„ˆë¬´ ì ì€ ìƒíƒœ. ì–‘ìˆ˜ëŠ” ê³§ íƒœì•„ì˜ ì†Œë³€(Fetal Urine)ì…ë‹ˆë‹¤.\n- **Mechanisms**:\n    1. **Renal Agenesis**: ì‹ ì¥ì´ ì•ˆ ë§Œë“¤ì–´ì§ (Potter sequence).\n    2. **Obstruction**: ìš”ë„ê°€ ë§‰í˜ (Posterior Urethral Valves).\n    3. **Placental Insufficiency**: íƒœë°˜ ê¸°ëŠ¥ ì €í•˜ â†’ íƒœì•„ í˜ˆë¥˜ ê°ì†Œ â†’ ì†Œë³€ ìƒì„± ê°ì†Œ.\n- **Complication**: **Variable Decelerations**. ì–‘ìˆ˜ê°€ ì—†ìœ¼ë©´ ì™„ì¶© ì‘ìš©ì´ ì‚¬ë¼ì ¸ íƒ¯ì¤„(Umbilical cord)ì´ ìê¶ ìˆ˜ì¶• ì‹œë§ˆë‹¤ ëˆŒë¦¬ê²Œ ë©ë‹ˆë‹¤.\n---","subject":"LM_obs1 2f646f2986ee80d3a4e8c9b5ab8a0b12","page_title":"LM_obs1 2f646f2986ee80d3a4e8c9b5ab8a0b12","episode":"LM_obs1 2f646f2986ee80d3a4e8c9b5ab8a0b12","section_path":["LM_obs1 2f646f2986ee80d3a4e8c9b5ab8a0b12"],"source_doc_id":"LM_obs1 2f646f2986ee80d3a4e8c9b5ab8a0b12","source_page":null,"source_anchor":"LM_obs1 2f646f2986ee80d3a4e8c9b5ab8a0b12-21"}
{"chunk_type":"recap_summary","text":"# ğŸ”¥ Rapid Fire Recap: Must-Know High Yields\nStep 2 CK ì‹œí—˜ ì§ì „ í™•ì¸í•  í•µì‹¬ ìš”ì•½ì…ë‹ˆë‹¤.\n| **Clinical Scenario** | **Likely Physiology / Diagnosis** | **Key Action / Concept** |\n| --- | --- | --- |\n| **Pregnant, Cr 1.0 mg/dL** | **Pathologic** (Renal Insufficiency) | ì„ì‹  ì¤‘ ì •ìƒ Crì€ 0.4~0.8ì„. 1.0ì€ ë¹„ì •ìƒ. |\n| **Right Flank Pain, Mild Hydro** | **Physiologic Hydronephrosis** | Progesterone + Uterus ì••ë°•. reassurance (if no infection). |\n| **Back Pain, Waddling** | **Lordosis** (Hyper-lordosis) | MRI ê¸ˆì§€. Conservative management (Reassurance). |\n| **Trauma, Rh- Mom** | **Fetomaternal Hemorrhage** | **Kleihauer-Betke Test**ë¡œ ì¶œí˜ˆëŸ‰ í™•ì¸ í›„ RhoGAM ìš©ëŸ‰ ê²°ì •. |\n| **Induction â†’ Seizure/Confusion** | **Water Intoxication** | Oxytocinì´ **ADH**ì™€ êµì°¨ ë°˜ì‘í•˜ì—¬ Hyponatremia ìœ ë°œ. |\n| **Low Amniotic Fluid** | **Oligohydramnios** | ì›ì¸: Renal issue / Placental insufficiency. ê²°ê³¼: **Cord Compression** (Variable Decels). |\n**Verbatim Dictation (0:00 ~ 0:30)**\n\"Welcome back to the wards. Go ahead and drop your bag in the team room, maybe grab a coffee. We're getting right to work. Yep, time to prep. And today we're tackling an absolute monster of a topic. We are. We're opening up the Fetus section of the study stack for this deep dive. Our mission today is mastering the clinical logic behind sections 3.0 through 3.4. We're talking Gestational Age, Fetal Surveillance... The heart rate patterns that give everyone anxiety. And of course the absolute alphabet soup of prenatal testing.\"\n---\n# ğŸ“ **The Wards: Fetus Section (3.0 - 3.4) Study Stack**\n## 1. Introduction: The Fetus\nUSMLE Step 2 ì¤€ë¹„ë¥¼ ìœ„í•œ **Fetus Section (Section 3.0~3.4)** ê°•ì˜ë¡ì…ë‹ˆë‹¤.\nì„ìƒì ìœ¼ë¡œ ê°€ì¥ ê¸°ì´ˆê°€ ë˜ëŠ” **Gestational Age(ì¬íƒœì£¼ìˆ˜)**ë¶€í„°, ëª¨ë‘ë¥¼ ë¶ˆì•ˆí•˜ê²Œ ë§Œë“œëŠ” **Fetal Heart Rate Pattern**, ê·¸ë¦¬ê³  ë³µì¡í•œ **Prenatal Testing**ê¹Œì§€ ë‹¤ë£¹ë‹ˆë‹¤. ë‹¨ìˆœíˆ ì•”ê¸°í•˜ëŠ” ê²ƒì´ ì•„ë‹ˆë¼, *Clinical Logic*ì„ ì´í•´í•˜ëŠ” ê²ƒì´ í•µì‹¬ì…ë‹ˆë‹¤.","subject":"LM_obs1 2f646f2986ee80d3a4e8c9b5ab8a0b12","page_title":"LM_obs1 2f646f2986ee80d3a4e8c9b5ab8a0b12","episode":"LM_obs1 2f646f2986ee80d3a4e8c9b5ab8a0b12","section_path":["LM_obs1 2f646f2986ee80d3a4e8c9b5ab8a0b12"],"source_doc_id":"LM_obs1 2f646f2986ee80d3a4e8c9b5ab8a0b12","source_page":null,"source_anchor":"LM_obs1 2f646f2986ee80d3a4e8c9b5ab8a0b12-37"}
{"chunk_type":"transcript_chunk","text":"---\n## 2. Section 3.1: Gestational Age (The Foundation)\nëª¨ë“  ì‚°ê³¼ì  ê²°ì •ì˜ ê¸°ì¤€ì´ ë˜ëŠ” ê°€ì¥ ì¤‘ìš”í•œ íŒŒíŠ¸ì…ë‹ˆë‹¤. ì•„ê¸°ê°€ Pre-termì¸ì§€ Post-termì¸ì§€, ì˜ ìë¼ê³  ìˆëŠ”ì§€ íŒë‹¨í•˜ë ¤ë©´ ì •í™•í•œ ë‚ ì§œê°€ í•„ìˆ˜ì…ë‹ˆë‹¤.\n### ğŸ“… The Dating Dilemma\n- **Clinical Scenario:** ìƒë¦¬ ì£¼ê¸°ê°€ ë¶ˆê·œì¹™í•œ í™˜ìê°€ ë‚´ì›í–ˆëŠ”ë°, ë§ˆì§€ë§‰ ìƒë¦¬ì¼(LMP) ê¸°ì¤€ìœ¼ë¡œëŠ” 14ì£¼ ê°™ì§€ë§Œ, Fundal heightëŠ” ì‘ê²Œ ëŠê»´ì§€ëŠ” ìƒí™©. ëˆ„êµ¬ë¥¼ ë¯¿ì–´ì•¼ í• ê¹Œìš”?\n- **The Golden Rule:** â˜… **History is useless, Trust the Tech.**\n- **Gold Standard:** **First Trimester Ultrasound** (íŠ¹íˆ **Crown Rump Length, CRL**).\n    - LMP(Last Menstrual Period)ëŠ” ë°°ë€ì¼ ë³€ë™, ë¶€ì •í™•í•œ ê¸°ì–µ ë“±ìœ¼ë¡œ ì¸í•´ ì˜¤ì°¨ê°€ í½ë‹ˆë‹¤.\n    - ë°˜ë©´, **First Trimester Ultrasound** (7~10ì£¼ ì‚¬ì´)ëŠ” ì˜¤ì°¨ ë²”ìœ„ê°€ **Â±3~5ì¼** ì •ë„ë¡œ ë§¤ìš° ì •ë°€í•©ë‹ˆë‹¤.\n    - ì´ë•Œ ì •í•´ì§„ Due Date(ì¶œì‚° ì˜ˆì •ì¼)ëŠ” ì„ì‹  ê¸°ê°„ ë‚´ë‚´ ë³€í•˜ì§€ ì•Šê³  ê³ ì •ë©ë‹ˆë‹¤(Locks in).\n### ğŸ“ Later in Pregnancy (No early US)\në§Œì•½ í™˜ìê°€ ì´ˆê¸° ì´ˆìŒíŒŒ ì—†ì´ ëŠ¦ê²Œ ë‚´ì›í–ˆë‹¤ë©´? **Fundal Height**ë¥¼ ì‚¬ìš©í•©ë‹ˆë‹¤.\n- **Rule:** 20ì£¼ ì´í›„ë¶€í„°ëŠ” **Fundal Height (cm) â‰ˆ Gestational Age (weeks)** (ì˜¤ì°¨ Â±2~3cm).\n- **Key Landmarks:**\n    - **Umbilicus (ë°°ê¼½):** ì•½ **20 Weeks**.\n    - **Xyphoid Process (ëª…ì¹˜):** ì•½ **36 Weeks**.\n- **âš ï¸ The Trap:** 40ì£¼ê°€ ë˜ë©´ íƒœì•„ê°€ ê³¨ë°˜ìœ¼ë¡œ ë‚´ë ¤ê°€ë©´ì„œ(Lightening/Engagement), Fundal heightê°€ ì˜¤íˆë ¤ 36ì£¼ ìˆ˜ì¤€ë³´ë‹¤ ë‚®ì•„ì§ˆ ìˆ˜ ìˆìŠµë‹ˆë‹¤. ì´ë¥¼ ì„±ì¥ ì§€ì—°ìœ¼ë¡œ ì°©ê°í•˜ë©´ ì•ˆ ë©ë‹ˆë‹¤.\n---\n## 3. Section 3.2: Fetal Surveillance (\"Is the baby okay?\")\nì—„ë§ˆê°€ \"ì•„ê¸°ê°€ ì˜ ì•ˆ ì›€ì§ì—¬ìš”\"ë¼ê³  í•  ë•Œ ê°€ì¥ ë¨¼ì € í•´ì•¼ í•  ì¼ì…ë‹ˆë‹¤.\n### ğŸ’“ Step 1: Non-Stress Test (NST)\n- **Target:** **Reactive NST**.\n- **Criterion (15x15 Rule):** 20ë¶„ ë™ì•ˆ **15 bpm ì´ìƒ ìƒìŠ¹**í•˜ëŠ” Accelerationì´ **15ì´ˆ ì´ìƒ ì§€ì†**ë˜ëŠ” ê²ƒì´ **2ë²ˆ ì´ìƒ** ë‚˜íƒ€ë‚˜ì•¼ í•¨.\n- **Physiology:** íƒœì•„ì˜ Sympathetic NS(êµê°ì‹ ê²½)ê°€ ì˜¨ì „í•˜ê³ , Brainstemì— ì‚°ì†Œê°€ ì˜ ê³µê¸‰ë˜ê³  ìˆë‹¤ëŠ” ëœ» (Neurologic check).\n- **Problem:** NSTê°€ **Non-reactive (Flat strip)**ì¼ ë•Œ.\n    - **Most Common Cause:** â˜… **Fetal Sleep Cycle** (ì•„ê¸°ê°€ ìê³  ìˆìŒ).\n    - **Action:** **Vibroacoustic Stimulation** (Buzzerë¡œ ê¹¨ìš°ê¸°) í˜¹ì€ ê²€ì‚¬ ì‹œê°„ì„ 40~60ë¶„ìœ¼ë¡œ ì—°ì¥.\n### ğŸ“Š Step 2: Biophysical Profile (BPP)\nNSTê°€ ì—¬ì „íˆ Non-reactiveë¼ë©´ **BPP**ë¡œ ë„˜ì–´ê°‘ë‹ˆë‹¤. (NST + Ultrasound)\n- **Scoring:** 5ê°€ì§€ í•­ëª© (ê° 0ì  or 2ì , ì´ 10ì  ë§Œì ).\n    1. **NST** (Reactive?)\n    2. **Fetal Breathing**\n    3. **Gross Body Movement**\n    4. **Fetal Tone** (Extension/Flexion)\n    5. **Amniotic Fluid Index (AFI)** â˜…\n- **Acute vs Chronic Markers:**\n    - **Acute Markers:** Tone, Movement, Breathing (ì €ì‚°ì†Œì¦ ì‹œ ë¹ ë¥´ê²Œ ì†Œì‹¤ë¨).\n    - **Chronic Marker:** â˜… **Amniotic Fluid (AFI)**.\n        - **Pathophysiology:** íƒœì•„ê°€ ë§Œì„±ì ì¸ Hypoxia ìƒíƒœë©´, ì¤‘ìš” ì¥ê¸°(Brain)ë¡œ í˜ˆë¥˜ë¥¼ ë³´ë‚´ê³  ì‹ ì¥(Kidney)ìœ¼ë¡œ ê°€ëŠ” í˜ˆë¥˜ë¥¼ ì¤„ì„ â†’ ì†Œë³€ëŸ‰ ê°ì†Œ â†’ **Oligohydramnios (ì–‘ìˆ˜ ê³¼ì†Œ)** ë°œìƒ.\n- **Management based on Score:**\n    - **8~10ì :** ì•ˆì‹¬ (Reassuring).\n    - **6ì :** ì• ë§¤í•¨ (Equivocal) â†’ 24ì‹œê°„ ë’¤ ì¬ê²€.\n    - **0~4ì :** ë¹„ì •ìƒ (Abnormal) â†’ â˜… **Immediate Delivery**.\n---\n## 4. Section 3.3: Fetal Heart Rate (Intrapartum Logic)\në¶„ë§Œ ì¤‘ íƒœì•„ ì‹¬ë°•ë™ ëª¨ë‹ˆí„°ë§ í•´ì„ì…ë‹ˆë‹¤.\n### ğŸ“ˆ Baseline & Abnormalities","subject":"LM_obs1 2f646f2986ee80d3a4e8c9b5ab8a0b12","page_title":"LM_obs1 2f646f2986ee80d3a4e8c9b5ab8a0b12","episode":"LM_obs1 2f646f2986ee80d3a4e8c9b5ab8a0b12","section_path":["LM_obs1 2f646f2986ee80d3a4e8c9b5ab8a0b12"],"source_doc_id":"LM_obs1 2f646f2986ee80d3a4e8c9b5ab8a0b12","source_page":null,"source_anchor":"LM_obs1 2f646f2986ee80d3a4e8c9b5ab8a0b12-47"}
{"chunk_type":"transcript_chunk","text":"- **Normal:** 110 ~ 160 bpm.\n- **Tachycardia (>160):** ê°€ì¥ í”í•œ ì›ì¸ì€ **Maternal Fever** (ì˜ˆ: **Chorioamnionitis**).\n- **Bradycardia (<110):** Maternal Hypothermia, Beta-blockers, í˜¹ì€ **Maternal Lupus (SLE)**.\n    - **SLE Connection:** ì—„ë§ˆì˜ Anti-Ro/La í•­ì²´ê°€ íƒœë°˜ì„ ê±´ë„ˆ íƒœì•„ì˜ ì „ë„ê³„(Conductive system)ë¥¼ ê³µê²© â†’ **Congenital Heart Block**.\n### ğŸ“‰ Decelerations (VEAL CHOP Logic)\n1. **Variable Decelerations (V)** â†’ **Cord Compression (C)**\n    - ëª¨ì–‘: ë‚ ì¹´ë¡œìš´ \"V\" ëª¨ì–‘ (Sharp drop).\n    - **Solution:** ê¸°ê³„ì ì¸ ë¬¸ì œ(ì¤„ ëˆŒë¦¼)ì´ë¯€ë¡œ ê¸°ê³„ì ìœ¼ë¡œ í•´ê²°. **Maternal Repositioning** (ì—„ë§ˆ ìì„¸ ë³€ê²½).\n2. **Early Decelerations (E)** â†’ **Head Compression (H)**\n    - ëª¨ì–‘: ìˆ˜ì¶•ê³¼ í•¨ê»˜ ë–¨ì–´ì§€ê³  ìˆ˜ì¶•ê³¼ í•¨ê»˜ íšŒë³µ (Mirror image).\n    - **Meaning:** ì•„ê¸° ë¨¸ë¦¬ê°€ ê³¨ë°˜ì— ë¼ë©´ì„œ ëˆŒë¦¬ëŠ” ê²ƒ. **Physiologic (ì •ìƒ)**. ê·¸ëƒ¥ ì§€ì¼œë³´ë©´ ë¨.\n3. **Late Decelerations (L)** â†’ **Placental Insufficiency (P)** â˜… (Emergency)\n    - ëª¨ì–‘: ìˆ˜ì¶•ì´ ì •ì (Peak)ì„ ì°ì€ *ë’¤ì—* ì‹¬ë°•ìˆ˜ê°€ ë–¨ì–´ì§€ê¸° ì‹œì‘í•¨.\n    - **Pathophysiology:** íƒœë°˜ ê¸°ëŠ¥ ë¶€ì „ìœ¼ë¡œ ìˆ˜ì¶• ì‹œ ì‚°ì†Œ ê³µê¸‰ì´ ì•ˆ ë¨.\n    - **Action:** **Intrauterine Resuscitation**.\n        1. **O2** ê³µê¸‰.\n        2. **IV Fluids** (í˜ˆë¥˜ëŸ‰ ì¦ê°€).\n        3. **Reposition** (íƒœë°˜ ì••ë°• í•´ì œ).\n        4. **Stop Pitocin (Oxytocin)** (ìˆ˜ì¶• ì¤‘ë‹¨).\n    - ê·¸ë˜ë„ ì•ˆ ë˜ë©´? â†’ **C-Section**.\n4. **Sinusoidal Pattern** â†’ **Anemia (Fetal)**\n    - ëª¨ì–‘: ë¶€ë“œëŸ¬ìš´ Sine íŒŒí˜• (Smooth sine wave).\n    - **Meaning:** íƒœì•„ì˜ ê·¹ì‹¬í•œ ë¹ˆí˜ˆ(Severe Anemia/Hypoxia). ë‡Œê°€ ì‹¬ë°• ì¡°ì ˆ ëŠ¥ë ¥ì„ ìƒìŒ. **Red Alert!** (ì˜ˆ: Vasa Previa í„°ì§, Rh incompatibility ë“±).\n---\n## 5. Section 3.4: Prenatal Testing (Alphabet Soup)\nScreening(ì„ ë³„ ê²€ì‚¬)ê³¼ Diagnostic(í™•ì§„ ê²€ì‚¬)ì„ êµ¬ë¶„í•˜ëŠ” ê²ƒì´ í•µì‹¬ì…ë‹ˆë‹¤.\n### ğŸ©¸ Routine Labs (Initial Visit)\n- Blood Type & Rh Status (Rh- í™•ì¸).\n- Infection Screen: HIV, Syphilis, Hep B, Rubella/Varicella immunity.\n- **Urine Culture:** ì¦ìƒì´ ì—†ì–´ë„(**Asymptomatic**) ë°˜ë“œì‹œ ì¹˜ë£Œí•´ì•¼ í•¨ (â†’ **Pyelonephritis** ì§„í–‰ ìœ„í—˜ ë†’ìŒ).\n### ğŸ•° Timeline Specifics\n- **24~28 Weeks:** **Gestational Diabetes Screen** (1hr Glucose Challenge Test). ì‹¤íŒ¨ ì‹œ 3hr í™•ì§„ ê²€ì‚¬. (Rh- ì‚°ëª¨ëŠ” ì´ë•Œ Antibody screen ì¬ê²€).\n- **35~37 Weeks:** **GBS (Group B Strep) Swab**.\n    - Positive ì‹œ: ë¶„ë§Œ ì¤‘ **Intrapartum Antibiotics (Penicillin)** íˆ¬ì—¬.\n### ğŸ§¬ Aneuploidy Screening (Down Syndrome ë“±)\n- **First Trimester Screen:**\n    - PAPP-A + Beta-hCG + **Nuchal Translucency (NT)**.\n    - Down Syndrome Pattern: **High hCG**, **Low PAPP-A**, **Thick Nuchal Translucency**.\n- **Cell-Free DNA (NIPT):** ì •í™•ë„ê°€ ë§¤ìš° ë†’ì§€ë§Œ ì—¬ì „íˆ **Screening** Testì„. ì–‘ì„±ì´ ë‚˜ì˜¤ë©´ ë°˜ë“œì‹œ í™•ì§„ ê²€ì‚¬ê°€ í•„ìš”í•¨.\n- **Second Trimester (Quad Screen):**\n    - **Trisomy 21 (Downs):** **HI**gh markers (**H**CG, **I**nhibin A) / Low markers (AFP, Estriol). (**HI** = **Hi**gh).\n    - **Trisomy 18 (Edwards):** **E**verything is **low** & depressed (AFP, Estriol, hCG, Inhibin A ëª¨ë‘ ë‚®ìŒ).\n- **Diagnostic Tests (Confirmation):**\n    - 10~13ì£¼: **CVS (Chorionic Villus Sampling)**.\n    - 15~20ì£¼: **Amniocentesis (ì–‘ìˆ˜ì²œì)**.\n---","subject":"LM_obs1 2f646f2986ee80d3a4e8c9b5ab8a0b12","page_title":"LM_obs1 2f646f2986ee80d3a4e8c9b5ab8a0b12","episode":"LM_obs1 2f646f2986ee80d3a4e8c9b5ab8a0b12","section_path":["LM_obs1 2f646f2986ee80d3a4e8c9b5ab8a0b12"],"source_doc_id":"LM_obs1 2f646f2986ee80d3a4e8c9b5ab8a0b12","source_page":null,"source_anchor":"LM_obs1 2f646f2986ee80d3a4e8c9b5ab8a0b12-67"}
